City University of New York (CUNY)

CUNY Academic Works
Dissertations, Theses, and Capstone Projects

CUNY Graduate Center

10-2014

Development and Applications of Mass Spectrometric Methods
for Phosphorylation Analysis
Hsin-Pin Ho
Graduate Center, City University of New York

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/gc_etds/432
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

DOCTORAL DISSERTATION

DEVELOPMENT AND APPLICATIONS OF MASS
SPECTROMETRIC METHODS FOR PHOSPHORYLATION
ANALYSIS
by

Hsin-Pin Ho

A dissertation submitted to the Graduate Faculty in Chemistry in partial fulfillment of the
requirements for the degree of Doctor of Philosophy, The City University of New York
2014

@2014
HSIN-PIN HO
All Rights Reserved

ii

Approval Page

This manuscript has been read and accepted for the Graduate Faculty in Chemistry in satisfaction of
the dissertation requirement for the degree of Doctor of Philosophy.

09/14/2014

Dr. Emmanuel J. Chang

Date

Chair of Examining Committee

09/16/2014

Dr. Brian Gibney

Date

Executive Officer

Dr. Amy Ikui
Dr. Yi He
Dr. Adam Profit
Supervisory Committee

THE CITY UNIVERSITY OF NEW YORK

iii

Abstract
Development and Applications of Mass Spectrometric Methods for Phosphorylation Analysis
by
Hsin-Pin Ho
Advisor: Dr. Emmanuel J. Chang
Protein phosphorylation modification regulates numerous cellular functions by a reversible
and selective control of kinases and phosphatases. To understand the entire dynamic network of
phosphorylation requires sensitive and reliable quantification of phosphorylation, measurements that
can be achieved by mass spectrometry. In this research, we established efficient MALDI-mass
spectrometric methods as strategies for single- or multi-site phosphorylation quantification without
the use of isotopes, chromatography and calibration curves. The methods were assessed by
analyzing peptide standards with different single-multiple phosphorylation sites, showing a wide
dynamic range, good accuracy and reproducibility. This is the first label-free MALDI method
without using a calibration methodology proposed for quantification of in vitro phosphorylation in a
kinase assay.
Moreover, advanced mass spectrometry empowers identification of a highly conserved Cdk2
phosphorylation site of HIV-1 reverse transcriptase (RT) at Thr 261 across thousands of HIV-1
strains. We demonstrated phosphorylation on HIV-1 RT peptides and protein in in vitro assays, and
confirmed phosphorylation in vivo with antibodies and mutation studies. Blocking this
phosphorylation by p21, a naturally occurring Cdk inhibitor, defines a potential Cdk2-mediated cellintrinsic mechanism for restricting HIV-replication in a clinically significant way.
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1.1

Objectives and rationale of the study
The objectives of this study are to develop label-free mass spectrometric methods for

quantification of single or double-site phosphorylation (chapter 2), and to investigate Cdk (cyclindependent kinase) phosphoryaiton in HIV-1 reverse transcriptase (RT) by mass spectrometry-based
techniques (chapter 3). The organization of the dissertation is described below.
This chapter introduces the background of Cdk phosphorylation and gives specific examples
of phosphorylated Cdk substrates. The following text depicts essential parts of an analytical
biological mass spectrometers (including desorption ionization and mass analyzers but emphasizing
the techniques applied to this thesis), and the state-of-the-art in tandem mass spectrometry. The
approaches of mass spectrometry are described instrumentally and methodically for protein
phosphorylation identification and quantification.
In Chapter 2 includes two projects with a mutual goal - to develop label-free mass
spectrometric strategies as alternatives for quantitative phosphoproteomics due to its low cost and
convenience. The first project is to establish an efficient MALDI-mass spectrometric method, called
Double Reciprocal Isotope-free Phosphopeptide Quantification (DRIP-Q), as the first proposed
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isotope-free and calibration-curve-free MALDI-MS method for phosphorylation quantification. The
results as follows include 1) a mathematic approach for phosphorylation quantification; 2) the effect
of laser energy on phosphorylation quantification; 3) linearity, dynamic range and reproducibility; 4)
validation of phosphorylation quantification by comparison with isotope dilution MALDI-MS; 5)
applications to Cdk inhibition.
The second project in Chapter 2 is to utilize high sensitivity and specificity of MS 3 to
determine double-site phosphorylation of aquaporin, in which two different phosphorylation sites
occur on Ser-256 and Ser-261 in response to vasopressin-dependent short-term regulation (2006
Hoffert, 2010 Xie). The MS3 method proposed overcomes the difficulties in isomeric
phosphopeptide stoichiometric analysis by CID based MS/MS without the use of isotopes. The
results obtained of 1) MS2 and MS3 analyses of AQP-2 peptides; 2) a mathematic approach by using
MS3 fragmentation for double phosphorylation site quantification; 3) consistency of MS3 fragment
ratios; 4) the effect of collision energy on quantification; 5) quantitative dynamic range; and 6)
applications to in vitro kinase assay will be discussed.
In Chapter 3, the project (in collaboration with Mathias Litchterfeld’s group at
Massachusetts General Hospital) uncovered a cell-intrinsic mechanism of HIV-1 reverse
transcription associated with Cdk2 phosphorylation. The results strongly suggest that p21 indirectly
blocks HIV-1 reverse transcription by inhibiting Cdk2-dependent phosphorylation of RT, including
the following parts: 1) Host Cdks support HIV-1 reverse transcription in CD4+ T cells; 2) HIV-1 RT
is a substrate for Cdk2-dependent phosphorylation; 3) substitution of T216 by Alanine reduces
HIV-1 RT; 4) Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation; 5) Cdk2-dependent
phosphorylation increases function and stability of HIV-1 RT; 6) p21 suppresses Cdk2-dependent
HIV-1 RT phosphorylation.

2

1.2

Protein Phosphorylation
Most eukaryotic proteins selectively and specifically undergo covalent modification to

regulate protein functions after being translated from mRNA (2005 Yang; 1995 Newton).
Phosphorylation is one of the most important post-translational modifications in the human cells,
occurring on serine/threonine/tyrosine residues in a number of proteins via catalytic addition of
phosphate group from adenosine triphosphate (ATP) (2003 Mann). Protein phosphorylation is
controlled by a wide variety of kinase and phosphatases, which themselves may be regulated by
phosphorylation. Once a protein is phosphorylated by a kinase, the phosphorylation event can cause
conformational and functional changes of the protein to either activate or de-activate the protein –
an effective way to regulate protein functions (1993 Johnson). Here, we review the literature on Cdk
phosphorylation, a very important post-translational modification in cellular regulation, and describe
specific examples of Cdk phosphorylation substrates.
1.2.1

CDK phosphorylation
In the 1970s and 1980s, Cyclin-dependent kinases (Cdks), a family of serine/threonine

protein kinases, were discovered as key regulators of the cell cycle in eukaryotic cells via
phosphorylation by Hartwell, Hunt, and Nurse who were awarded the Nobel Prize in Physiology or
Medicine for 2001 (1995 Morgan; 1989 Hartwell; 1989 Gould; 1983 Evans). Cdk complexes are
composed of a Cdk catalytic subunit and a cyclin subunit, i.e. Cdk2/cyclin A. The activation of
cyclin-Cdk complexes requires the binding of the cyclin subunit, phosphorylation activation on a
conserved threonine (Thr160) in the Cdk activation loop by Cdk-activating kinase (CAK) (1995
Morgan), and, in some cases (e.g. multisite phosphorylation), interaction with Cdc kinase subunit
(Cks) protein (1996 Pines, 1996 Bourne, 2011 Balog).
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Differences in cyclin-Cdk complexes give specificity of phosphorylation to particular
substrates and sites in cells. For example, some cyclins contain a docking domain, a small
hydrophobic patch for helping recruit their correct substrate to Cdks by interacting with an RXL
motif on the specific substrates (2007 Ubersax, 2011 Kõivomägi). A slight change in the sequences
of the hydrophobic patches of different cyclins can lead to proper substrate recognition by either
increasing local concentration of the kinase around the substrate, or orientating the substrate in the
kinase active site, even though it still remains unclear if the Cdk complex binds to the RXL motif
and the phosphorylation site on the substrate synchronously, especially for multiple phosphorylation
sites on a substrate (2007 Ubersax).
The Cdk’s sequences are complementary to the specific substrate’s sequences through
hydrophobic interactions, charge-charge interactions or hydrogen bonding (1995 Jeffrey). Cdks
have a canonical catalytic domain composed of β-sheets in a small N-terminal lobe and α-helices
in a larger C-terminal lobe. The ATP binding is found at a hydrophobic pocket between the two
lobes where the adenosine moiety is buried with the phosphate backbone exposed to the solvent.
The catalytic domain catalyzes the transfer of the terminal γ-phosphate moiety to the hydroxyl
phosphorylation site on the substrate, which interacts to the kinase. The substrate consensus
phosphorylation sites for Cdks 1, 2, 4, 5, and 6 (2010 Errico) are S/T-P-X-K/R, where S/T
represents the phosphorylated residue, and X represents any amino acids followed by basic residues,
K/R. The phosphorylated site “P” (S/T) is followed by a Pro residue, which contains a unique
nitrogen atom among the 20 amino acids. Because the nitrogen atom is part of rigid pyrrolidone side
chain ring; it cannot act as a hydrogen donor. Any other residue at P+1 is unfavorable owing to the
existence of uncompensated hydrogen bonds from substrate to a main-chain nitrogen atom. The
Pro residue at P+1 also constrain the conformation of the substrate, allowing a basic residue (K/R)
at P+3 to interact with the phospho-Thr 160 in the kinase (1999 Brown).
4

Cks (cyclin-dependent kinase subunit), a subunit of Cdks, is a relatively small protein (9-18
kDa), interacting with Cdk complexes in the control of cell cycle, has been identified since 1980’s;
however researchers have long been tantalized by the implication of Cks for modulation of specific
Cdk activity (1996 Pines) and their precise function still remains elusive. The crystal structures of the
Cks proteins as a part of a complex with Cdks have been solved (1996 Bourne), suggesting Cks
binds Cdks as a monomer, although Cks also exists as a dimer. The exchange of the monomeric
and dimeric states of Cks via its conserved β -hinge region regulates Cdks-Cks association and
thereby regulates Cdk enzymatic activity (2006 Bader, 2001 Bousseau). Two highly conserved
residues (Pro93 and Pro95) in the hinge region of Cks have been observed its role in tuning the
dimerization equilibrium, and recently proposed to associate with formation of Cdk-Cks interface by
stabilizing conformation for binding (2011 Balog). Besides, the structural data revealed a conserved
cationic pocket that weakly binds to free phosphate as well as other anions, and interacts with the
Cdk active site. Cks is considered as a phosphoadaptor subunit of the cyclin-Cdk-Cks complexes,
positioning the kinase complex to phosphorylated substrates and promoting multiple
phosphorylation, which occurs in clusters in majority of Cdk substrates (2013 Koivomagi). Cks
binding sites have been predicted to preferentially occur in Cdk substrates that contain multiple
phosphorylation sites, and more likely to be found in phosphorylated substrate on a Cdk consensus
site (mostly Thr) nearby the phosphorylated Cdk consensus site (2013 McGrath).
1.2.2

Specific examples of phosphorylated Cdk substrate
Protein phosphorylation modification involves addition of phosphate to a protein. The

bulky phosphate with a double negative charge, therefore, alters a protein’s physical and biochemical
properties, and induces conformational changes that are responsible for the biological protein
functions, such as activity, stability and interaction (2007 Singh; 2009 Li; 2010 Deribe). Several well-
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studied Cdk phosphorylation substrates involved in regulation of cell cycle and other biological
processes have been reported. Some specific examples are introduced below.
Sic1 acts as one of the important regulators through phosphorylation in cell cycle, a process
of cell duplication and division, in Saccharomyces cerevisiae. The cell cycle is an ordered bio-event,
including four phases, G1 phase (gap1, a growth phase for the cell) - S phase (DNA synthesis) - G2
(gap2, a second growth phase for the next division) – M phase (mitosis, a process of cell division).
Sic1 associates with Cdk1/cyclinB complexes to regulate the G1/S transition in yeast via proteolysis
caused by phosphorylation as a part of the intrinsic cell cycle machinery. When Sic1 is
unphosphorylated, the Cdk1/cyclinB stays inactive, whereas the inactive Cdk1 kinase complex is
switched into active state by Sic1 degradation through its multiply phosphorylation by Cdk1 on the
minimum six of nine Cdk consensus sites (1997 Verma, 1999 Hodge). One thing to note is that the
multiple phosphorylation of Sic1 is stimulated by Cks in the early stage of phosphorylation,
occurring after Cdk consensus site (T5 or T33) on Sic1 which is first phosphorylated by Cdk1. The
phosphorylated T5 or T33 (Cks consensus sites) is recognized by Cks to induce multiple
phosphorylation, allowing the binding of Cdc4, and consequently inducing Sic1 degradation. The
Sic1 degradation is necessary for Cdk activation, leading to initiation of the following DNA
synthesis (S phase) in the cell cycle (2011 Koivomagi).
Schizosaccharomyces pombe Wee1 and Cdc25 (cell division cycle 25 homolog A) are,
respectively, negative and positive regulators of Cdk1 protein kinase activation and localization
during the G2/M transition. During the period of late S and G2 phase, cyclin B synthesis increases,
promoting the binding of cyclin B to Cdk1. The Cdk1/cyclinB complexes are normally held in an
inactive state as a result of phosphorylation of Cdk1 on Tyr15 by Wee1 (1994 Coleman, 1996 Lew,
2007 Perry). Wee1 and Cdk1 show mutual regulation: Wee1 itself is first phosphorylated and
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activated by Cdk1/cyclinB undergoing multiple site phosphorylation with opposing threshold
control by Cdc55-mediated dephosphorylation. A switch-like inhibitory phosphorylation of Cdk1 by
activated Wee1 is then induced by Cks proteins that interact with the Cdk1 active site and
phosphorylated Cks consensus sites on Wee1. During the M phase, dephosphorylation of Cdk1 by
phosphatase Cdc25 (a key regulator of mitotic entry) converts the kinase complexes into an active
state, and leads to the progress of cell division. The activation of Cdk1 occurs in a stepwise manner
controlled by a dynamic equilibrium between phosphorylation (de-activating) and dephosphorylation (activating) of Cdk1; phosphorylation of Cdk1 is regulated by the multiplephosphorylation state of Wee1. Intinitally during M phase, Cdk1 is held in a state of low activity for
spindle assembly, while later the activity is switched to a state of high activity for spindle elongation
at the time of highest expression of cyclin B (2011 Harvey). The activities of Wee1 and Cdc25
appear to be oscillated in opposition to one another, similar to their balanced roles in Cdk1
inhibition and activation (2005 Harvey).
Beside the cell cycle control, a host protein SAMHD1, associated with restriction of
HIV-1 replication in myeloid and quiescent CD4+ T cells, is regulated by Cdk phosphorylation (2013
Cribier). SAMHD1 is one of the identified HIV-1 restriction factors, and consists of a sterile alpha
motif (SAM) and a HD domain. It has been reported that SAMHD1 acts as a host restriction
nuclease that can convert nucleotide triphosphates to a nucleoside and triphospate. In the presence
of SAMHD1, HIV-1 infection appears to be blocked by reducing the level of dNTPs to a level too
low to be available to a complete reverse transcription step. It has been observed that Cyclin
A2/Cdk1 and Cyclin A/Cdk2 complexes phosphorylate SAMHD1 at its Thr 592 residue both in
vitro and in vivo (2013 Cribier, 2014 St Gelais), whereas the phosphorylated SAMHD1 was
significantly reduced in the PMA treated cells without affecting the level of unphosphorylated
SAMHD1. A mutagenesis experiment showed that a Cdk phosphorylation-defective mutant
7

(T592A) has sufficient ability to inhibit HIV-1 replication in both of the PMA treated and untreated
cell. In other words, the phosphorylation of SAMHD1 may play a role in a negative regulator of its
restriction activity toward HIV-1. The authors proposed that the restriction activity of SAMHD1
may be regulated by the equilibrium between Thr 592 phosphorylated and unphosphorylated forms
favored in the proliferating cells (untreated cells), and non-proliferating cells (treated cells),
respectively (2013 Cribier, 2014 St Gelais).
1.3

Mass spectrometry
Mass spectrometry is an analytical technique that determines mass-to-charge ratio (m/z) of

ionized molecules. In MS analysis, analytes are ionized and volatilized in the source, separated by
m/z in the analyzer, and counted in the detector. MS not only provides m/z of the molecules, but in
some cases also disintegrate the molecular ions into particular fragmentation pattern for qualification
and quantification through tandem mass spectrometry (MS/MS). Typically, a mass spectrometer
consists of an inlet system, ion source, a mass-selective analyzer, an ion detector and data system
(see Figure 1.1). There are a variety of combinations of the MS ion sources and analyzers designed
for different analytical purposes.

Figure 1.1 Schematic illustration of the MS instrument setup
8

1.3.1

Desorption Ionization
Mass spectrometers determine the mass-to-charge ratio (m/z) of gas-phase molecular ions

generated in an ion source. Successful MS analyses are mainly dependent on the volatilization and
ionization of analytes in a sample. In biological mass spectrometry, because the large polar
biomolecules, such as proteins and polypeptides, are non-volatile, it has been challenging to desorb
the macromolecules without decomposition into smaller charged particles until desorption
ionization techniques was developed. Currently, the majority of biological MS is couple to one of the
two desorption ionization techniques: Electrospray ionization (ESI) and matrix-assisted laser
desorption ionization (MALDI).
ESI is an ionization process by which molecules was directly desolvated from solution-phase
into gas-phase under atmospheric pressure. In the late 1980s, John Fenn, the 2002 Nobel Prize
Laureate in Chemistry, applied ESI to convert liquid solution of large molecules into gas ions for
MS. The ESI technique made a breakthrough for MS to be attributed to the applications of LC-MS
in biochemistry. In ESI, the analytes are first dissolved in a solution of sufficient ionic strength,
sprayed through an ESI needle with 2-5 kV voltages, positive or negative, that results in the
accumulation of ions with identical charge polarity formed at the droplet surface at the tips of the
capillary relative to vacuum orifice. To evaporate the neutral solvent molecules from the droplet
surface, an inert gas flow is directed to the droplets to the spray exit where a “Taylor cone” shape is
formed. As a result, the charge density increases while the droplet size decreases. When the coulomb
repulsion between the like charges on the droplet surface exceeds the forces of surface tension
(Rayleigh instability limit), the droplets break into smaller highly charged droplets. The same process
occurs many times until only one charged analyte molecule is left in single droplet. The lone ions
thus are ejected into the gas phase by electrostatic repulsion entering into the mass spectrometer to
be analyzed (Figure 1.2).
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Figure 1.2 Schematic illustration of electrospray ionization.

MALDI-MS is based on the concept of laser desorption mass spectrometry proposed in
1976, in which pulsed laser has been employed to produce intact gas phase ions from solid samples
(1976 Macfarlane). Figure 1.3 shows a scheme graph of MALDI. In the early investigation of laser
desorption mass spectrometry, before the development of MALDI, only a few short peptides could
be ionized and generate intact ions. Successful ionization was highly dependent on the specific
physical properties of the peptides. In 1985, Hillenkamp and Karas first mentioned of the term
“matrix-assisted laser desorption” in a publication, reporting the observations of intact protonated
molecular ions of amino acids and dipeptides under different influence of UV- laser wavelength for
desorption (1985 Karas). One of the experiments shows that the intact molecular ion of alanine was
produced in the presence of tryptophan at an irradiation of about a tenth of that necessary for
obtaining spectra of alanine alone. The authors proposed that the tryptophan acted as an “absorbing
matrix” which absorbed excess of the laser energy and transfer appropriate energy to the nonabsorbing to generate a soft ionization, yielding intact molecular ions. In 1988, Hillenkamp and
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Karas further performed experiments to successfully analyze bovine albumin (67 kDa) in the
presence of high concentration of nicotinic acid, and observed the intact ions (1988 Karas). In 1988,
Tanaka introduced another sample preparation method into MALDI-TOF-MS for detection of
intact ions of large proteins, such as lysozyme (14 kDa) and chymotrypsinogen (26 kDa), by mixing
an ultra fine cobalt powder with glycerol in an organic solvent and dropped a few microliters of the
mixed solution onto a sample holder where sample solution is placed (1988 Tanaka). Both methods
were a breakthrough in the application of MALDI-TOF-MS extended to include analysis of highmass molecules (proteins). Although today’s technique typically employs the use of a small organic
acid similar to Hillenkamp and Karas’s method, Tanaka was awarded the Nobel Prize in chemistry in
2002.

Into mass analyzer
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Figure 1.3 Schematic illustration of matrix assisted laser desorption ionization.

11

1.3.2

Mass Analyzer
After being ionized to charged gas-phase particles ion an ionization source, sample ions are

analyzed depended on their mass (m) and charge (z) in a mass-selective analyzer. In order to
accurately separate and measure the m/z of the ions, the mass analyzer should be operated under
high vacuum and calibrated by using ions of known m/z. There are five major types of mass
analyzers: (i) Sector (magnetic or electric), (ii) Time-of-flight (TOF), (iii) Fourier Transform-IonCyclotron Resonance (FT-ICR), (iv) Quadrupole, (v) Ion trap. Different analyzers have different
capabilities. In general, the analyzers are separated into two categories: high resolution (Sector, TOF
and FT-ICR) and low resolution (Quadruple and ion-trap). High-resolution analyzers have better
ability to distinguish between ions of high m/z, i. e. intact protein ions, than low-resolution
analyzers, whereas, the speed of data processing of high-resolution analyzers can be limited. In
recent years, hybrid analyzers are designed to include more-than-one analyzer with compensatory
advantages of individual analyzers; it therefore causes the use of hybrid analyzers to rapidly become
a popular technique to achieve high performance.
TOF analyzers separate ions of different m/z traveling with their mass-dependent velocities
in space when the same voltage is applied. The TOF analyzers are commonly combined with
MALDI ionization technique. After being ionized in the source, all ions gain the same amount of
kinetic energy from an acceleration voltage. Therefore, the energy allows the ions to drift through a
field-free flight tube under a vacuum with different velocities (K.E.=1/2 mv2 = zV; where KE, m, v,
z are the kinetic energy, the mass of the ion, the velocity, the charge of the ion, and the applied
voltage, respectively). In other words, for same distance, ions with larger m/z values fly more slowly,
whereas ions with smaller m/z values fly faster to the detector; thus different drifting time can be
recorded with respect to each m/z value. The TOF analyzers are advantageous of very high mass
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range with high resolution and high sensitivity, although it requires high vacuum, and high
voltage/pulsed/high precision electronics.
Sector or magnetic analyzers also separate ions in space according to their m/z values
detected at different location. Most sector analyzers are of double focusing design, including an
electrostatic analyzer and magnet sector. Ions formed in the ion source pass through the electrostatic
analyzer, where the ions of different energy are trajected along different paths toward the magnet
sector. The magnet field is set up perpendicular to the path of the ions, leading to ions of identical
m/z but different energy are brought to same focus at a single point on the detector. This
combination of the electrostatic analyzer and magnet sector creates a high-resolution sector mass
spectrometer with typical accuracy of 1-5 ppm (1997 Russell). The double focusing magnetic sector
mass analyzers provide reproducibility with the best quantitative performance of all mass
spectrometer analyzers, such as high resolution, high sensitivity, high dynamic range, but it is not
well-suited for pulsed ionization methods (e.g. MALDI), and the instrument itself is usually bulky
and higher cost than other mass analyzers.
FT-ICR analyzers measure m/z values of ions based on the cyclotron motion of ions
caused by cyclotron frequency in a strong magnetic field. It is similar to a sector analyzer in that a
magnetic field combined with electric field is used, but an ICR analyzer traps all ions inside of an ion
trap (a cell) into an orbit by a centripetal force counterbalanced by a Forentz force (perpendicular to
both the ions velocity and magnetic field lines) (2001 Schmid). In the cell, ions with the identical
m/z have identical cyclotron frequency but differences in energies, orbital radii, and consequently
velocities in their orbits. To obtain measurable signals, the ions are then excited by a pulse of a radio
frequency, generating a larger cyclotron radius. As the ions pass by the detection plates, an “image
current” is induced. The complex signals are converted by Fourier Transformation (FT) from the
time domain to the frequency domain, which can be further converted into a m/z spectrum. In

13

contrast to the magnetic sector analyzers, ICR is well suited for use with pulsed ionization methods
(e.g. MALDI), has the highest recorded mass resolution of all mass spectrometer, and has powerful
capability for MS/MS experiments. However, it suffers from a limited dynamic range and high cost
of high vacuum and cryogenic cooling to lower signal to noise ratios. Besides, the accuracy is subject
to space charge effects and ion molecule reactions, once ions are overfilled in the cell.
Quadrople analyzers are resonance mass filters that consist of four parallel rods in a square
cylinder configuration. The ions are passed through the quadruple in a combination field of a direct
current (DC) and a radio frequency (RF) voltage. Ions of each m/z value have their stable trajectory
within a range of DC and RF values. In general, the DC and RF voltages are ramped together at a
particular ratio, letting ions with a particular m/z value through the quadrupole to the detector at a
time. The benefits of the quadruple analyzer include good reproducibility, relatively small and lowcost systems, but it has limited resolution, and is not well suited for pulsed ionization methods.
Ion trap analyzers, analogous to the quadrupole, utilize ion path stability of ions for
separating them by their m/z by adjusting a direct current voltage and radio frequency (RF) voltage.
There are two configurations: three-dimensional quadrupole ion trap (3D-QIT), also called Paul
traps) and a new generation two-dimensional linear ion trap (2D-LIT). Paul and Steinwedel invented
the 3D-QIT in the early 1950’s after the development of electrodynamic quadrupole (1953 Pual).
The 3D-QIT is a compact and inexpensive analyzer, which consist of a ring electrode with end caps
on the top and bottom. The trap has high scan speed and high selectivity and sensitivity of tandem
mass spectrometry (MSn). In the last decade, 2D-LIT was induced to increase the capacity and
loading efficiency of the trap and reduce space-charge problems (changes in ion motion), resulting
from too many ions in the trap that causes the mutual coulombic interaction of ions, and
consequently induce mass shift and lower the resolution and accuracy observed. The details of the
ion trap analyzers will be described in the following section.
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Orbitrap analyzer is a new type of high-resolution mass spectrometer, composed of an
outer barrel-like electrode and a central spindle-like electrode along the axis (2008 Perry). As the
name suggests, Orbitrap is considered an ion trap analyzer, but there is no RF or magnetic used to
control ion stability. In Orbitrap, ions are trapped and oscillated into orbits between the two
symmetric electrodes, where a DC voltage applied results in the electrostatic potential distribution-a
combination of quadrupole and logarithmic potentials. The axial oscillation frequencies, which are
exclusively dependent on m/z but not on initial velocities as well as coordinates of ions, can be
detected by measuring the image current on the outer electrodes. The time-domain frequency signals
are further converted into m/z values shown on a spectrum. Similar to FT-ICR, advantages of the
Orbitrap include high resolving power (up to 150,000), multi-fragmentation capability and high
sensitivity in the attomole to femtomole range for measurements of intact proteins, whereas
Orbitrap may outperform FT-ICR because of increased space charge capacity at higher masses,
larger trapping volume, and, most importantly, a cryogen-free detection system (2005 Hu, 2006
Macek).
Hybrid mass spectrometers combine more than one type of mass analyzer that each has
their own pros and cons. The hybrid capability allows for the combination of the different desirable
performance characteristics offered by various types of analyzers into one mass spectrometer (2008
Glish). Most importantly, the hybrid analyzer provides a platform to perform MS/MS experiments
with high resolving power, accuracy and analysis speed; e. g., ions are mass-selected in the first
analyzer, reacted and the product ions are then analyzed in the second analyzer. Although perhaps
more than 30 configurations of hybrids have been explored, only a few have been commercialized
and remain popular, such as Q-TOF, Ion trap-TOF, and LIT-Orbitrap (2012 Paulo). In early years,
most research was devoted to MS/MS sector instrumentation. However, in 1978, Yost and Enke
first published MS/MS results in a triple quadrupole system – a key development in hybrid MS/MS
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mass spectrometry. The next year, upon the comparison of different performance characteristics of
various analyzers, it was observed that the MS/MS collision in QqQ hybrid instruments required
lower energy but was more efficient than the collision used in Sector instruments (2008 Glish).
Later, in the 1980’s, Glish and Goeringer at Oak Ridge National Laboratory combined a quadrupole
mass filter with a TOF analyzer (Q-TOF) (1984 Glish), which has later become one of the most
popular mass spectrometers currently used due to the main advanced design of Orthogonal
Acceleration that is placed between the quadrupole and TOF analyzer for minimizing the effect of
different ion entrance velocities, leading to a high resolution. As the quadrupole is operated in RFonly mode, all ions are passed from the ion source as an ion beam to the orthogonal acceleration
region, where a acceleration pulse is applied orthogonal to the direction of the entering ions to send
the ions down the flight tube. This Q-TOF hybrid design exploits the higher MS/MS efficiency,
which was demonstrated for QqQ in early years, and the high performance in sensitivity, resolution,
and accuracy of a TOF analyzer. Subsequently, TOF was coupled to ion trap analyzers, very similar
to Q-TOF, to offer high MSn capability and high resolving power and mass accuracy at the same
time. The most recent type of commercialized hybrid instrument is LIT-Orbitrap with an ion
collector “C-trap” between the two analyzers. Instead of a continuous stream, the ions are
accumulated in LIT while another packet of ions is collected by the C-trap and ejected into Orbitrap
(2008 Perry).
1.3.3

MS techniques applied to this thesis – MALDI-LIT MS
Most of the research presented in the thesis is carried out by MALDI-linear ion trap (LIT)

MS. In early years, the MALDI technique was typically combined with TOF because of the pulsed
nature of MALDI that easily interfaces with pulsed TOF measurements, especially with
implementation of delayed-ion extraction (1995 Brown; 1995 Vestal) and, which allow for the better
reproducibility, accuracy, and resolution. Nowadays, MALDI is coupled to nearly every MS analyzer
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available for various experiments, utilizing its high tolerance for contaminants, simple sample
preparation, high sensitivity and wide analytical mass range. Although abundance of sample
preparation methods and a wide range of matrices have been proposed and applied to MALDI
analysis, the detailed mechanism is not totally understood and still being investigated. It is generally
accepted that MALDI is a soft ionization with a combination of desorption and ionization (2006
Knochenmuss) divided into two steps. The first step is to form gas-phase primary ions, i.e.
protonated matrix ([M+H+]); the second step is to involve proton transfer from the primary ions to
an analyte (A) through gas phase ion-molecule reaction to produce protonated analyte secondary
ions, i.e. [M+H]+ + A  M + [A+H]+.
MALDI is an extremely complex ionization, involving many desorption/ionization events
that occur in a micro to nanosecond during or shortly after laser ablation. Over the last decade,
scientists have proposed differing hypotheses that attempt to explain the complicated ionization
mechanism in a somehow unpredictable manner. The mechanism for the formation of ion-molecule
secondary ions is less controversial than the formation of primary ions. The mechanism for the
formation of primary ions proposed in the literature mainly encompasses two models, the gas-phase
proton transfer model (2006 Knochenmuss; 1987 Karas) and the cluster (lucky survivor) model
(2000 Karas; 2006 Alves; 2002 Fournier).
In the gas-phase proton transfer model, desorption is initiated by photoionization, where
matrix absorbs photon energy from laser ablation and transfers it into excitation energy causing the
formation of matrix primary ions. However, the mechanism is insufficient to explain how the highmass protein molecules can be desorbed from the matrix and suspended into the gas phase. In the
cluster model, similar to the mechanism of ESI proposed by John Fenn, upon the laser ablation, the
gas-phase charged clusters may be produced by ion evaporation mechanism described by Iribarne
and Thompson (1967 Iribarne). The most notable assumption in the cluster model is that all the
17

ions may exist in the sample before laser ablation; during ablation, the desorbed cluster ions are reneutralized in gas phase, but only a few “lucky survivor” ions can survive as singly charged ions
detected. Yet, a problem is why the formation of low charged ions is much more favorable than that
of highly charged ions during desorption if proteins can carry several charges, which was commonly
observed in ESI (Figure 1.4) (2012 Trimpin). Recently, both models were discussed by Jaskolla and
Karas, reporting that both of the gas-phase proton transfer pathway and the lucky survivor pathway
are true under multiple investigations, and both pathways may be part of one overall MALDI
mechanism (2011 Jaskolla), but the details still remain problematic.
The typical MALDI sample preparation involves dissolving a small organic acid (mostly
aromatic compounds used for efficient energy absorption during laser ablation) at a high
concentration in an organic solution, mixing sample solution with excess matrix, spotting the
mixture of sample and matrix on a MALDI plate, and allowing the sample to co-crystalize with the
matrix prior to analysis. Several important factors determining a successful MALDI analysis in
sample preparation steps are choice of matrix and matrix solvent, the ratio of matrix to sample,
concentrations of samples, consideration of analyte nature (i.e. the compatible solubility of matrix
and analyte), homogeneity of spots, and possible contamination that affects signal-to-noise ratios on
spectra. A wide variety of matrices have been used in MALDI dependent on specific analytes. Three
common matrices for peptides and proteins are α-cyano-4-hydroxycinnamic acid (CHCA), 2,5dihydroxybenzoic acid (DHB), and sinapinic acid (SA) (Figure 1.5).
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Figure 1.4 Electrospray Ionization (ESI) and Matrix Assisted Laser Desorption Ionziation
(MALDI). (A/B) an ESI/MALDI mass spectrum of a protein. (C) charge states and
corresponding mass-to-charge ratios (m/z) of the protein.

Figure 1.5. Typically used matrices in MALDI-MS.
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Linear Ion Trap analyzer (LIT)
Before the development of LIT, the ion-trap analyzers were designed as a 3D-cylindrical
symmetry mass analyzer (3D-QIT), roughly the size of a tennis ball, made up of a central ring
electrode and two end caps on the top and bottom (1990 Paul; 1991 Cooks; 1997 Jonscher) (Figure
1.6). In the 3D trap, ions of a particular range of m/z can be trapped in an oscillating electric field
around the inner electrode with the damping gas (helium) by applying a RF oscillating potential to
the ring electrode (the end cap electrodes are held at an offset DC potential to prevent ions from
escaping axially) for a certain time interval. The presence of the helium gas in the trap is to stabilize
the ion trajectories and, if MS2 is employed, to collide with the molecule ions. After that, the ratio
frequency amplitude is ramped (an additional auxiliary radio frequency voltage, 1/3 frequency of the
main voltage, is applied) over a period of time to destabilize the ion trajectories and then eject the
ions toward the detector.

Figure 1.6 Three-dimentional ion trap configuration with central ring electrode
and two end-cap electrodes.
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2D-LIT analyzers have evolved recently (2002 Schwartz; 2002 Hager) (Figure 1.7). The
physical appearances of the LITs are more closely related to those of quadrupoles, but the LITs are
still designed based on the principle of the QITs. As shown in Figure 1.7., the quadrupole was cut
into three axial sections, including the front section, the end section, and the x rod of the central
section. The three sections are connected a discrete DC potential and two different phases of RF are
applied to each pair of two opposite electrodes, allowing the ion trajectories take the shape of
sausage along the z-axis rather than at a single center point of 3D-QIT. This results in greatly
increase the trap’s capacity and decrease the space charge effects. Another advantage of LIT is that
ions will not be ejected from the front and the end section, but from the x rod of the central section
to the two detectors placed axially on either side of the rods. Thus, a large amount of ions entering
axially can be detected to reach maximum sensitivity. The LIT analyzer has been shown to
successfully overcome two fundamental limitations of the traditional 3D-QITs, ion capacity and trap
efficiency. The further combination of LTQ with other high resolution analyzers, such as LIT-TOF
(qTOF) and LIT-Orbitrap, has provided powerful tools for biomolecule analysis.

Figure 1.7 Two-dimentional linear ion
trap configuration with the quadrupole
rods cut into three axial sections.
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1.3.4

Tandem Mass Spectrometry (MS/MS)
MS/MS is a technique where ion fragmentation occurs in a collision chamber before the

mass spectrum is acquired. The fragment information is useful for peptide/protein sequencing,
structural elucidation, analyte identification and quantification through fragment fingerprinting.
Several approaches to MS/MS experiments (product ion scan, precursor ion scan and neutral-loss
scan) can be conceived in two ways: in time or in space with collision induced dissociation (CID), the
most commonly used method of fragmentation, also called collisionally activated decomposition
(CAD) (2002 McClellan). Tandem-in-space MS/MS generally is performed on magnetic sectors and
quadruple based mass spectrometers. The processes occur sequentially in separate regions of the
instruments. In the first region, which is most often a quadruple filter, specific ions (precursor ions)
are induced into the subsequent part of the instrument, a gas-filled collision chamber, for
fragmentation. All fragment ions (product ions) further enter into the third section of the instrument
to be scanned (see Figure 1.8). Tandem-in-time MS/MS can be performed by an ion trap mass
spectrometer with, for example, product ion scan which acquires a mass spectrum of products ions
produced by retaining a precursor ion in the trap chamber for a period of time for and colliding the
ion with a damping gas, such as helium.

+
Ionization

+

+
MS1

+
Fragmentation

(Mass Separation)

+

+
+

Precursor Ion

MS2
(Mass Separation)
Product Ion

Figure 1.8 Schematic illustration of tandem mass spectrometry.

22

Detector

MS/MS experiments can be classified into three types (precursor ion scans, neutral loss
scans, and product ion scans), according to which these species are monitored. During MS/MS,
specific ions (precursor ions) are selected based on m/z values and collided with a collision gas into
fragments (product ions). Precursor ion scanning is to detect a range of m/z of precursor ions as a
particular m/z of the product ions is fixed. Neutral loss scanning is to synchronously scan both
precursor and product ions, but offset by a constant m/z value corresponding to a specific neutral
loss fragment. Product ion scanning is to scan product ions (fragments) derived from an isolated
precursor ion of only a selected m/z. Because analyte ions have been isolated from the background
ions for detection, MS/MS, is able to strongly reduce the background, leading to a lower detection
limit achieved and higher signal-to-noise ratios shown in MS/MS spectra, in most cases. Moreover,
tandem-in time MS analyzers (traps) have capability of performing multi-fragmentation (MSn), in
which specific ions can be selected for further fragmentation sequentially from the previous MS/MS
step. The controllable MSn experiments are usually applied to structure elucidation due to its power
to continually break down any interested analyte fragments into smaller pieces to gain a better
understanding of the structure or sequence of a peptide. Thus, tandem MS (MS/MS or MSn) has
been widely applied to qualitative and quantitative proteomic analysis with the advantages of high
sensitivity and selectivity, providing abundant tandem mass spectra with specific fragmentation
information needed for structural identification (1990 Johnson).
A peptide sequence is composed of three types of bonds that can be fragmented along the
amino acid backbone: CH-CO, CO-NH, and NH-CH. A nomenclature for peptide sequencing by
MS/MS was originally proposed by Roepstorff et al., and later modified by Biemann (1984,
Roepstorff; 1988, Biemann). Figure 1.9 illustrates six possible fragment ions for each amino acid
residues, caused by the three potential cleavage sites along the sequence backbone. The a, b, and c
ions are formed due to charge retention on the N-terminal fragment, whereas the x, y, z ions
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originated from the charge retention on the C-terminal fragment. Upon CID fragmentation, the
cleavage occurs at the CO-NH bonds, resulting in dominant b and y ions shown on MS/MS spectra.
The fragment ions are structurally useful for determining a peptide sequence.

b - y : CID cleavage site
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Figure 1.9 Peptide sequence fragmentation

1.4
1.4.1

Protein identification and phosphorylation analysis in MS
MS protein identification approaches
Two fundamental MS protein identification approaches are termed “top-down” and

“bottom-up”. In top-down protein analysis, intact proteins are introduced into MS without
proteolytic digestion and are fragmented into smaller peptide cations or neutral fragments. In
bottom-up proteomics, purified proteins are treated with a protease to perform proteolytic digestion
before being subjected to fragmentation for MS analysis.

24

Bottom-up proteomics measures exact mass of peptides from digests derived from proteins
to identify the corresponding proteins; and determining fragments of the digest peptides to know
structural information. The conventional bottom up approaches can be gel-based or gel free.
Proteins are first extracted from a sample of cells, and the protein mixture is separated by one or
two-dimensional gel or online liquid chromatography (2014 Magdeldin). The two-dimensional gel
separates proteins by their isoelectric point and then by its masses using a standard one-dimensional
gel. Once the proteins are isolated from one another, the individual protein bands of interest are cut
out and digested enzymatically with a suitable enzyme (typically with trypsin) or chemically with a
strong acid (such as 12% formic acid) into small peptides (digests) which are then extracted prior to
MS analysis. Because the peptides have the better solubility and ionization efficiency, it is possible to
readily detect the peptides by MS, compared to the parent proteins (2006 Chait). The mass spectra
(peptide mass fingerprinting) from its proteolytic digestion are assigned to proteins by comparison
with a sequence database. In addition, with the use of MS/MS, partial amino acid sequences of
individual peptides can be obtained to further characterize and confirm the sequence.
With top-down analysis, the proteins remain intact without any digestion before being
introduced into MS (2011 Zhang). To determine modifications in the protein sequence, the exact
mass measurement of the intact protein is compared to with calculated values based on the DNApredicted protein sequence; then, the target protein is isolated and fragmented in gas phase by
tandem MS for sequence mapping. However, the top-down approach still suffers from several
limitations currently. Because high-mass proteins yield complex isotopic distribution patterns shown
on the mass spectra, the top-down MS requires a costly high-resolution mass analyzer at high-mass
range, such as Orbitrap or FT-ICR, to avoid any overlapping of the distributions. In addition to the
complex isotopic distribution, multiply charged proteins generated in ESI after chromatographic
separation also results in complex spectra. For intact protein tandem MS, poor dissociation

25

efficiency (low sequence coverage) has been observed for very large proteins when many common
dissociation processes such as CID are used, and the mechanism of gas phase protein fragmentation
is not fully understood, even though many researchers have turned their attention to develop new
fragmentation methods and the instrumentation (one such method is electron-transfer dissociation
(ETD) that generates c- and z-type fragment ions and preserves unstable side-chain modification
during MS/MS). Moreover, the ionization efficiency for very large proteins is limited, leading to
difficulty of trace analysis of the large protein. For these reasons, most of the protein MS
identification and quantification still relies on bottom-up approaches.

1.4.2 Phosphorylation analysis in MS
Phosphorylation occurs at least 30% of proteins in human (2007 Ubersax). A new phosphate
group induces a conformational change of target proteins that can be activated, deactivated, or
changed in function. Numerous cellular functions are regulated by protein phosphorylation, a
reversible and selective reaction controlled by kinases and phosphatases. The kinases and
phosphatases have been found to be involved in a large number of human diseases, resulting from
their mutation, over expression or malfunction (2001 blume-Jensen). Phosphoproteomics with
recent advances in mass spectrometry (MS) has become an important approach to understand the
entire phosphorylation network, for example, which protein are phosphorylated; which sites are
phosphorylated on the proteins; what is the stoichiometry of these phospho-sites; which kinase
phosphorylates the site; what is the biochemical function of the phospho-event; what is the cell
biological function of the phosphor-event.
Traditionally, to trace phosphorylation, radioactive 32P is introduced into cellular proteins via
the transfer of α-phosphate of labeled ATP by kinases (1986 Garton). Another method is to utilize
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antibodies against phosphorylated proteins by western blotting (1999 Dimmeler). The probing
methods are sensitive and highly selective; however, they provide no information of specific
phosphorylation sites, unless specific antibodies are produced against each phosphorylation site on a
protein, and phosphorylation on differing sites has to be determined individually, which can be
prohibitively expensive. MS is a powerful tool for probe-free phosphorylation analysis in which the
attached phosphate group can be observed on mass spectra with a mass shift of +80 Da. The
specific mass difference between modified and unmodified proteins suggests the presence of protein
modifications (2004 Chang). A number of MS strategies have been developed to perform
phosphorylation quantification, yet the technique is being explored to find better and more efficient
quantification approaches.
In phosphoproteomic analysis, the phosphorylated proteins firs t are isolated from tissues or
cells, digested into peptides subjected to bottom-up analysis, or directly subjected to top-down
analysis by mass spectrometry for site-specific identification and quantification. However, the
dynamics

and

heterogeneity

of

protein

phosphorylation

increase

complexity

of

the

phosphoproteomic analysis, leading to the challenge of deciphering phosphorylation cellular
signaling network. For instance, the same residue may be phosphorylated by several kinases through
a variety of mechanisms at different time. Furthermore, the phosphorylation level of a substrate
fluctuates dynamically in the cellular network, i.e., some proteins containing phosphorylated residues
may be found to be strongly phosphorylated, weakly phosphorylated or un-phosphorylated as
functional proteins in cells (2013 Tyanova). To construct the detailed phosphorylation signal
pathways, it is therefore important to develop methodologies for identification and quantification of
the dynamic and heterogeneous phosphorylation.
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1.4.3

MS-based quantitative analysis
Measurement of phosphorylation stoichiometry is biologically important for understanding

the functional dynamics of phosphorylation regulation in a cell. To do this, MS has been regarded as
a powerful tool not only for protein identification but also protein quantification. MS-based
phosphorylation quantification can be classified into two major strategies: absolute quantification,
which determines the exact amount of proteins in the sample a quantified standard; and relative
quantification, which evaluates phosphorylation changes with experiments. Unfortunately, MS is not
inherently quantitative (2009 Doerr), because ionization efficiency of many peptides is different in a
given sample and the instrument responses are unpredictable. Many quantitative MS approaches
have also been developed to overcome this limitation. For instance, protein or peptide samples can
be isotopically labeled and the abundance of the labeled target can be relatively or absolutely
compared to the abundance of the nonlabeled or differently labeled target. Another quantitative
approach similar to the labeling method is called isotope dilution, which is used by spiking 13C-or
15

N-stable isotope analogs of peptide analytes in defined amount as internal standard before MS

analysis. Besides, due to a strong demand for a lost cost and rapid analysis, MS label-free approach
has been recently proposed to quantify protein or peptide amounts in different samples in response
to the changes in signal intensities.

Isotope labeling methods
MS-based relative quantitative proteomics can be achieved with comparison of two or more
samples by using stable isotope labeling methods. Some of the recently developed labeling methods
are: Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) (1999 Oda), Isobaric Tag for
Relative and Absolute Quantitation (iTRAQ) (2004 Ross), Stable Isotope Dimethyl labeling methods
(2009 Boersema). The SILAC method relies on the metabolic incorporation of a “heavy” or “light”
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form of a given protein or peptide with substituted13C6-Lys and 13C6, and 15N4-Arg residues. In
SILAC experiments, cells are grown in cell media where the control cell medium contains the natural
(light) proteins; whereas, the reaction medium (i.e. kinases treated) is prepared where the light amino
acids are replaced by heavy SILAC amino acids. The two cell populations are then mixed prior to
MS analysis, where a difference in MS signals between light and heavy masses of peptides represents
the quantitative difference in the target proteins between control and reaction medium. The ratio of
the light-to-heavy mass response is utilized for the relative proteomic quantification (i.e.
phosphorylation quantification).
The iTRAQ method uses tandem mass spectrometry (MS/MS) and isobaric labeling on the
primary amines of peptides and proteins. The iTRAQ reagents are four isobaric tags, which have an
identical total mass of 145 Da, consisting of three elements: a peptide reactive group (NHS ester) for
N-terminal labeling of peptides, a balance group (28- 31 Da) and a reporter group of variable mass
(m/z 114-117) with difference in the stable isotope composition of the reporter groups and the
balance groups, such as

13

C,

18

O and

15

N (Figure 1.10) (2004 Ross). The reagents tag samples

individually by replacing the peptide reactive group with primary amines of peptides and proteins
prior to MS/MS analysis, where the reporter group falls off from each tagged compounds,
producing different reporter fragment ions shown on the same mass spectrum for quantification.
The pattern of the reporter fragments shown as differing masses allows multiplexing four different
samples, and all samples could be identified and quantified in one tandem mass spectrometric run to
achieve a high throughput analysis (Figure 1.11).

29

Figure 1.10 The structure of iTRAQ reagent composed of a reporter
group, balance group and reactive group.

Figure 1.11 MALDI-MS workflow with iTRAQ labeling (m/z 114 – 117)
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In dimethyl labeling experiments, protein samples are first treated with protease, and free
amines on the derived peptides of different samples are labeled with normal or deuterated
formaldehyde. The labeled samples are then mixed and analyzed by LC-MS whereby the change in
mass of dimethyl labels is used to compare the peptide abundance in different samples. Demethyl
labeling is based on dimethylation of primary amines (the N terminus and the side chain of Lysine
residues) in a peptide mixtures with formaldehyde to convert the primary amines to dimethylamines.
It is observed that the differential peak mass by 28 Da for each derivatized sites and by 4 Da for
each isotopic dimethyl labels (Figure 1.12) (2009 Boersema). This method is rapid and economic to
globally detect and quantify phosphorylation by comparing the signal response with a mass shift by
labeling.

Figure 1.12 Labeling reactions of dimethyl labeling.

Isotope dilution methods
While isotope labeling methods mostly provide relative quantification, MS-based absolute
quantification is also possible for determining absolute abundance of phosphopeptides. Isotope
dilution has long been for small molecule quantification by the addition of defined quantities of
isotope standards as ideal internal standards, which have the chemical behaviors identical to the
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analytes. In the past decade, this approach has been transferred to absolute quantification of
proteins and peptides in biological samples. In 2003, Gygi et al. presented an absolute quantification
(AQUA) strategy in quantitative proteomics where proteins are proteolyzed with trypsin in the
presence of the synthesized isotope standards (AQUA peptides), followed by extraction,
chromatographic separation, and analysis using selected reaction monitoring (SRM) on triple
quadrupole mass spectrometers (2003 Gygi). The absolute phosphorylation quantification of a
tryptic peptide containing a specific phosphorylation site can be achieved by utilizing the ratios of
native and corresponding AQUA peptide chromatographic peak areas. A similar strategy was
described by Ciccimaro et al. to absolutely quantify phosphorylation of kinase activation loop of
cellular focal adhesion kinase (FAK) with addition of a labeled phosphorylated FAK standard and a
labeled control peptide along with the edogenous FAK before cell lysis and protein digestion,
respectively (2009 Ciccimaro). It is possible to calculate amount of phosphorylation of the
edogenous FAK by comparing the observed amount of the edogenous FAK to the amount of the
control peptide with corrections for immunoprecipitation efficiency during protein isolation from
cell lysate. Overall, this labeling dilution approach is, however, not used for a large scale analysis and
limited to the individual analyte, because of the difficulty of obtaining these internal standards,
especially when a large number of proteins have to be quantified.
Label-free methods
There has been growing interest in the use of label-free approaches to quantitative mass
spectrometry. Label-free phosphoproteomics allows samples to be directly and separately analyzed
by MS without merging (mixing of unlabeled and labeled samples), resulting in a higher coverage of
a dynamic range. It also has been reported that the measurements are linearly proportional to the
concentrations of interest peptides in the range of 10 fmol to 100 pmol (2012 Nilsson). Most
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importantly, a large amount of samples can be analyzed at the same time without the limit of the
number of labeling reagents.
There are two ways of determining the abundance of a peptide or protein in label-free
quantitative phosphoproteomics: (1) based on intensity changes in peptide peaks, (2) the spectral
counting of analytes after LC-MS/MS analysis. The former methods are conducted by comparing
ratios of intensities of phosphorylated to nonphosphorylated peptide ions. For example, Steen et al.
developed a label-free phosphorylation quantification method by using the measurements of
normalized ion intensities of phosphopeptide relative to nonphospho-tryptic peptides from the
target protein (2005 Steen). This method was further modified by Yi et al. to normalize the peakarea of the reconstructed ion chromatogram for the target phosphopeptide against the peak areas of
other nonphospho-tryptic peptides as endogenous internal standards (2007 Yi). The normalized
peak areas for untreated and treated samples were compared for relative quantification of
phosphopeptides. However, this method may be problematic for quantification of peptides
containing adjacent phosphorylation sites regulated more than one kinases.
The same research group, therefore, reported the latter method by monitoring MS/MS
product ions instead of parent ions for label-free phosphorylation quantification. The samples were
first tryptically digested, chromatographically separated, and then analyzed in MS. The intensities of
the MS/MS or even MSn fragments, in which b and y ions are unique to each phosphorylation
isoform, were applied to detect phosphorylated tryptic peptides in a linear and reproducible manner
(2010 Langlais). In general, the major limitation of label-free quantification is the requirement of
extra care of intersample preparation and purification for reducing matrix effect prior mass
spectrometric analysis; that explains why chromatographic separation coupled to ESI-MS has been
considered to be the most desirable platform for the label-free analysis in spite of the complexity of
its and time-consuming compared to MALDI-MS.
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Chapter 2: Development of label-free quantitative proteomic analytical method by using
matrix-assisted laser desorption/ionization (MALDI)-tandem mass spectrometry
2.1 Introduction
2.2 Label-free MALDI-MS for single-site phosphorylation quantification
2.2.1 Materials and methods
2.2.2 Results and discussion
2.2.2.1 Mathematic approach for phosphorylation quantification
2.2.2.2 Consistency of instrument response factor, a
2.2.2.3 Effect of laser energy on phosphorylation quantification
2.2.2.4 Linearity, dynamic range and reproducibility
2.2.2.5 Validation of phosphorylation quantification by isotope dilution MALDI-MS
2.2.2.6 Application
2.2.3 Conclusion
2.3 Label-free MALDI-MS for double-site phosphorylation quantification
2.3.1 Materials and methods
2.3.2 Results and discussion
2.3.2.1 Mass spectra of phosphorylated Aquaporin-2 isomers (pSer-256 and pSer-261)
2.3.2.2 Mathematic Approach for double phosphorylation site quantification
2.3.2.3 Consistency of MS3 fragment ratios of p261, β
2.3.2.4 Linearity, dynamic range and accuracy
2.3.2.5 Effect of collision energy on double phosphorylation quantification
2.3.2.6 Applications to in vitro kinase assays
2.3.3 Conclusion

2.1 Introduction
Phosphorylation is one of the most important post-translational modifications. Many
proteins have been known to be phosphorylated at numerous sites by kinases, resulting in a change
in function. To understand the special characteristics of phosphorylation requires analytical methods
to quantify either single or multiple phosphorylation sites within a substrate. Many methodologies
have been used to identify and quantify phosphorylation, such as western blotting, radioactive
phosphate labeling, flow cytometry, and mass spectrometry (1999 Kreegipuu, 2002 Zhang, 2008 Ma).
Mass spectrometry (MS) has become an irreplaceable technique in phosphorylation analysis, in
which a signal corresponding to the phosphate moiety can be detected on the mass spectrum,
because it has the capability to readily determine site-specificity, and does not require the generation
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of sequence-specific antibodies. The general workflow for MS based quantitative proteomic analysis
relies heavily on HPLC-ESI-MS technique in the combination with either labeling or labeling-free
method (shown in Figure 2.1A). Calibration curve construction generally is required, especially
when label-free methods are applied. Both the labeling and label-free methods for absolute and
relative quantification have pros and cons, as mentioned above in chapter 1. For instance, the
labeling methods are limited to high cost and less flexibility, but are generally considered more
reliable. Recently, label-free methods have attracted growing attention due to their simplicity,
reduced sample preparation and high analytical dynamic range; however the procedures of sample
preparation and chromatographic separation are a requisite for ESI-MS or ESI-MSn in the workflow
to reduce its spectral complexity and ion suppression effect. To overcome this conflict, MALDI has
great potential to replace the current ESI strategy to build up a simpler workflow for proteomic
analysis (Figure 2.1B).
ESI and MALDI are the most common ionization techniques generally used in protein mass
spectrometry (2011 Kuklenyik). ESI can produce multiple charged ions that could be problematic
while analyzing protein or peptide mass spectra due to the spectral complexity. Thus, for most
phosphoproteomic analyses, ESI-MS must be coupled to liquid chromatography to simplify the
complex spectra (2011 Zhang). Compared to ESI, MALDI has more tolerance to buffer or
impurities in the sample, so it requires only simple sample preparation, is generally fast and easy to
use, and yields simpler spectra (singly charged peptide ions) that ordinarily do not require
chromatographic separation. In spite of this, MALDI is inherently less quantitative due to
unpredictable difference in ionization efficiency and in absolute ion intensity arising from
heterogeneities in analyte/matrix crystallization.
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Figure 2.1 General workflow for proteomic quantification. (A) Current workflow with
ESI. (B) A simpler workflow proposed with MALDI in the study.
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To minimize the quantitative problems, isotope derivative methods are generally required in
quantitative proteomic MALDI by taking advantage of the fact that isotopomers respond identically
under MS conditions, but are able to be separated by mass. It has been recently demonstrated that
MALDI combined with isotope labeling methods is feasible to protein quantification in proteomic
analysis (2009 Johnson). While effective, such isotopic labeling methods are limited in their
multiplexing capacity, high cost, requirement for specialized reagents and a narrow dynamic range
(2012 Gunasekera, 2010 Gouw, 2010 Boersema, 2009 Ye). In addition, the inherent limitations in
reproducibility of MALDI-MS can at least in part be overcome by increasing the signal acquisition
time. The signal from a single spot can be interrogated for several minutes to average the signal from
thousands of laser shots, as compared to the smaller number of scans generally available when
limited by a chromatographic time scale in ESI-LC-MS.
Label-free strategies have been increasingly prominent as alternatives for quantitative
proteomics due to their lower cost and convenience. Liquid chromatography MS (LC-MS) has been
one of the fundamental techniques in the label-free relative-quantitative proteomics (2007 Levin,
2008 Asara). Chromatographic retention peaks can be integrated with external calibration to
measure peptide abundance (2010 Zhu). However, the chromatographic task is time-consuming and
may suffer from interference problems. Mobile phase conditions must also be carefully controlled to
avoid changing the solubility and ionization of the peptide analytes. As an alternative to
chromatography based label-free methods, label-free MALDI-MS methods are in rising demand for
high-throughput proteomic analysis. Kinumi et al. has successfully measured phosphopeptides
derived from the phosrestin protein by using a label-free MALDI approach with calibration
construction by plotting signal ratios versus peptide amount ratios, quantifying the ratio of
phosphopeptide to total peptide (2005 Kinumi). The calibration curve showed a linear correlation
between the peak ratios and amount ratios.
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In other cases, the unphosphorylated and

phosphorylated substrates have different ionization efficiencies, resulting from their differing
physicochemical properties. For example, a study by Parker, et al. demonstrated non-linear
relationships between signal ratios and amount ratios for seven different peptides using MALDI
ionization (2008 Parker). This may be due to differential ionization effects between the different
peptides. Therefore, in this chapter, to solve the problems, we aim to develop MALDI label-free
mass

spectrometric

strategies

as

alternatives

for

quantitative

single

or

double-site

phosphoproteomics with the advantage of lower cost, simplicity and convenience.
2.2

Label-free MALDI-MS for single phosphorylation quantification
In this study, we present a new MALDI-MS method for quantification of

phosphorylation

stoichiometry,

termed

Double

Reciprocal

Isotope-free

Phosphopeptide

Quantification (DRIP-Q). This method does not require isotope labeling, chromatography, or
construction of calibration curves. Instead, a double reciprocal transformation is applied that
accounts for differences in ionization efficiencies of analytes, allowing for the direct comparison of
unphospho- and phosphopeptide signals. The method is shown to be robust and reproducible over
a wide range of analyte concentrations using three different peptide models encompassing
phosphoserine, phosphothreonine and phosphotyrosine. The results obtained with this method are
comparable to those obtained using traditional stable isotope labeling. To our knowledge, this is the
first report of a calibration-curve-free MALDI-MS method for the determination of
phosphorylation.
2.2.1 Materials and methods
Materials
HPLC grade water, acetonitrile, and formic acid were purchased as HPLC grade from Fisher
Scientific (Pittsburg, PA, USA). Synthetic peptides, AAAAYRAAR, LRWGFTTPDKKHQKEPPF,
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and RQSVELHSPQSLPR, were used for the quantitative method development. The peptide,
AAAAYRAAR, and its phosphorylated form, AAAApYRAA, and their [13C3]-alanine labeled forms,
were synthesized and purified by University of Utah DNA/peptide facility. The HIV-RT peptides,
LRWGFTTPDKKHQKEPPF,

containing

a

Cdk

phosphorylation

consensus

sequence

(S/T)PXR/K, and its phosphorylated form, LRWGFTpTPDKKHQKEPPF, were synthesized in
house

using

standard

fmoc-based

solid-phase

peptide

chemistry.

The

AQP2-peptide,

RQSVELHSPQSLPR, and its two phosphorylated forms at pSer-256 and pSer-261,
RQpSVELHSPQSLPR, and RQSVELHpSPQSLPR, were purchased from Anaspec (Fremont, CA).
MALDI-MS quantitative analysis
Peptide standards, AAAAYRAAR (peptide 1), LRWGFTTPDKKHQKEPPF (peptide 2),
and RQSVELHSPQSLPR (peptide 3), and their phosphopeptides were selected as three different
model systems to establish the label-free MALDI-MS quantitative method. 1 μL of the sample
mixture of the unphospho- and phosphopeptide standards with various phosphorylation fractions
was mixed with 9 μL of matrix solution. Then, 1 μL of the peptide mixture with the matrix was
spotted on a MALDI plate prior to MALDI-MS analysis. MALDI-MS experiments were carried out
on a Thermo LTQ XL linear ion trap mass spectrometer (Thermo Scientific) was equipped with a
MALDI ion source. α-Cyano-4-hydroxycinnamic acid (CHCA) was purchased Sigma-Aldrich (St.
Louis, MO, USA) from 2,5-Dihydroxybenzoic acid (DHB) was purchased from Acros Organics
(Morris Plains, NJ, USA) and used without further purification. A saturated aqueous solution of aCyano-4-hydroxycinnamic acid (CHCA) (Sigma-Aldrich, St. Louis, MO, USA) in 0.1 %
trifluoroacetic acid/acentonitrol (30/70, v/v) or 2,5-Dihydroxybenzoic acid (DHB) (Acros Organics
Morris Plains, NJ, USA) mixed with water / acetonitrile (50/50, v/v) in a 1:4 ratio (v/v) was used
as a matrix solution. Full scan mass spectra were acquired in positive mode by 400 scans with
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automated gain control (AGC) set at 300,000 counts with automated spectrum filter (ASF) off, 3
microscan/step, and processed by XcaliburTM 2.0.7 software.

In vitro Phosphatase assay
The phosphopeptide (AAAApYRAAR) was applied to the phosphatase assay, which was
performed in a final volume of 50 μL, containing 25mM of Ammonium bicarbonate buffer, 4 Units
of Alkaline Phosphatase (Roche), and 1.56 nmole of the phosphopeptide substrate at 30 °C for 1 h.
The reaction was quenched by adding 20% acetic acid into the reaction sample, and heating it for at
90 °C for 10 min. A control (inactivated phosphatase) experiment was carried out by adding 20 μL
of 20% acetic acid and heating at 90 °C for 10 min before adding the substrate, so that the
phosphopeptide remained. The reaction and control samples were diluted and mixed in different
phosphorylation fractions. 1 μL of 2.83 – 0.31 pmole peptide substrates was subjected to MALDIMS analysis.
Isotope dilution MALDI-MS
[13C3]-alanine labeled unphosphopeptide U* (AAA*AYRAAR) and labeled phosphopeptide
P* (AAA*ApYRAAR) phosphorylated forms served as internal standards. The labeled standards
were mixed with the unlabeled standards (U and P) in 1:1 ratio with the amount ranging from 0.1 20 pmole/µL and analyzed by MALDI-LTQ. The amount of P and U in unknown samples was
determined by using calibration methodology. Calibration curves were constructed for each labeled
pair by plotting signal ratios of labeled to unlabeled peptides versus their amount ratios (i.e. the
signal ratios of P* to P versus their amount ratios; the signal ratios of U* to U versus their amount
ratios) (2011 Kuklenyik).

In vitro kinase assays
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To investigate Cdk inhibitor’s activity, Cdk2/CyclinA was assayed using 1.4 μM HIV-1 RT
peptide LRWGFTTPDKKHQKEPPF in the presence of 2 mM ATP and 1x NEBuffer (50 mM
NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New England BioLabs Inc.) at 30°C for 15
min with the addition of Cdk inhibitors, Roscovitine at a concentration of 0.1 μM to 5 μM or
Olomoucine, at a concentration of 1 μM to 50 μM. A control experiment was performed with no
inhibitor addition. Following the incubation, 1 μL of each sample was added into 9 μL of the matrix
solution for MALDI analysis. IC50 values are calculated by nonlinear regression analysis using
GraphPad Prism (version 6 Prism Software Inc.).
2.2.2 Results and Discussion
MS is a fast, high-throughput, and probe-free method for phosphorylation quantification.
Both HPLC-ESI-MS and MALDI-MS can be used for phosphorylation quantification. HPLC-ESIMS is considered to be more reproducible for phosphorylation quantification than MALDI-MS,
even though MALDI is advantageous due to its analytical speed and accommodation of more
complex samples. When used with isotope dilution quantitative strategy, MALDI-MS shows
improved precision and reproducibility for peptide quantification, whereas isotope-free MALDI
methods still face some challenges. For instance, phosphorylation may cause a change of ionization
efficiency, which will result in non-linearity between the signal ratios and actual mole ratios. This
condition has been previously observed in calibration curves for isotope-free MALDI-MS. To solve
the problem requires considering the difference of ionization efficiencies in quantification. Here, we
propose a new mathematic approach, called “Double Reciprocal Isotope-free Phosphopeptide
Quantification (DRIP-Q)” to find a linear correlation between signals and actual amounts for
phosphorylation quantification.
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2.2.2.1 Mathematic Approach for phosphorylation quantification
The DRIP-Q approach proposed here accounts for possible difference in ionization
efficiencies for a phosphopeptide (P) and its unphosphorylated analog (U). It requires the
assumption (which we later test experimentally) that signal intensity is directly proportional to
sample concentration, where the proportionality constant is defined as the ionization efficiency, I.
Therefore,
SP = IP × MP

(Eq. 1a)

SU = IU × MU (Eq. 1b)
where S, I and M represent observed mass spectral signal intensity, ionization efficiency and amount
in moles, and the subscript P or

U

represents the phosphorylated peptide or its unphosphorylated

analog.
Eqs. 1a and 1b can be combined to give:
𝑆𝑃
𝑆𝑈

=

𝐼𝑃

𝑥

(Eq. 2a)

𝐼𝑈 (1−𝑥)

where (x) is the mole fraction of phosphopepeptide P, and (1-x) is the mole fraction of U. For
example, if xi=0.1, 10% of the total peptide is phosphorylated.
Letting the signal ratio,

𝑆𝑃
𝑆𝑈

= 𝑦, and the instrumental response factor ratio

becomes:
𝑦 =𝑎 ×

𝑥

(Eq. 3b)

(1−𝑥)

Converting y = f(x) into x = f(y), yields:
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𝐼𝑃
𝐼𝑈

= 𝑎, the equation

𝑥 =

𝑦

(Eq. 3c)

(𝑎+𝑦)

Taking the reciprocal of both sides of equation gives
1
𝑥

A plot of

=𝑎 ×
1
𝑥

1
𝑦

versus

+1
1
𝑦

(Eq. 3d)

yields a straight line with a y-intercept of 1 and a slope of a. Therefore, once

the response factor ratio, a, has been determined, the phosphorylation fraction x could be calculated
by using the observed signal intensity ratio y of phospho- to unphospho-peptide. This method only
requires determination of a and y, and therefore avoids time-consuming calibration curve
construction.
2.2.2.2 Consistency of instrument response factor, a
For Eq. 3d to hold, the response factor ratio, a, must be constant. To investigate the linear
correlation between the reciprocals of the phosphorylation percentage

1
𝑥

and signal ratios

1
𝑦

in Eq.

3d, the response factor ratio was tested for three peptide models over a range of phosphopeptide to
unphosphosphopeptide concentration ratios. The three models (Table 2.1, data shown in Figure
2.2, ) include peptides that may be phosphorylated at tyrosine, threonine or serine.
For each model, the phosphopeptide and unphosphopeptide were mixed at nine different
mole fractions of phosphopeptide (x), and the response factor ratio a was determined for each
mixture from the observed mass spectrometric signal intensity ratio y. The response factor ratio is
found to be consistent across the range of concentrations for each model (Table 2), with RSDs for
a varying from 2.72% to 4.10% for the three models, confirming the linear correlation between
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1
𝑥

and

1
𝑦

in Eq. 3d. These results demonstrate the potential for applying Eq. 3d to quantification of

phosphorylation by isotope-free MALDI-MS.

Table 2.1 Instrument response factor (a) at different phosphorylation fractions (x)
Instrumental Response Factor Ratio, a
1b

xa

a
b
c
d
e

2c

xa

3ad

3bd

0.10

0.670

0.027

0.189

0.016

0.32

0.723

0.034

1.032

0.073

0.20

0.671

0.029

0.176

0.014

0.38

0.716

0.015

1.017

0.074

0.30

0.672

0.037

0.177

0.014

0.43

0.691

0.038

1.062

0.105

0.40

0.634

0.009

0.180

0.006

0.48

0.731

0.042

1.022

0.045

0.50

0.669

0.005

0.189

0.014

0.54

0.763

0.047

1.006

0.095

0.60

0.639

0.032

0.186

0.017

0.63

0.732

0.024

1.023

0.086

0.70

0.658

0.056

0.182

0.008

0.74

0.711

0.038

1.107

0.034

0.80

0.600

0.023

0.199

0.017

0.91

0.787

0.086

1.107

0.131

Average

0.652

0.184

0.733

1.047

R.S.D.e

3.94%

4.32%

4.15%

3.86%

phosphorylation fraction
peptide 1 and phosphopep. 1 (AAAAYRAAR, AAAApYRAA) within the range of 0.31 to 2.83 pmole
peptide 2 and phosphopep.2 (LRWGFTTPDKKHQKEPPF, RWGFTpTPDKKHQKEPPF) within the range of 0.14 to 1.26 pmole
peptide 3, phosphopeptide 3a, phosphopeptide 3b (RQSVELHSPQSLPR, RQpSVELHSPQSLPR, RQSVELHpSPQSLPR) within the range of 10.0-90.0 fmole
n =3
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2.2.2.3 Effect of laser energy on phosphorylation quantification
MALDI mass spectrometric signal response may vary with laser intensity. Changes in the
signal response might further affect the signal ratios (y) and the consistency of a values in Eq. 3d.
For example, low laser intensity may lead to low signal response due to the deficiency in sample
ionization, whereas excessively high laser intensity may produce a high signal background, lowering
the signal to noise ratio. To investigate the effect of laser intensity on the constant a in Eq. 3d,
peptide 2 in its unphosphorylated and phosphorylated forms were mixed at various phosphorylation
fractions (x), and were analyzed by MALDI with laser energies of 8 and 13 µJ. For each mixture,
the response factor ratio a value was calculated from the observed signal ratio (y) and the known
phosphorylation fraction (x). Average a values were 0.23  5.70% RSD and 0.16  4.40% RSD for 8
and 13 µJ, respectively (Table 2.2). These results indicate that changes in laser intensity can
differentially affect the ionization efficiencies of the un-phosphorylated and phosphorylated
peptides, but the ionization efficiency ratio a is consistent with a small RSD at a constant laser
energy across a wide range of phosphorylation fractions. As a result, care should be taken to ensure
that the same laser intensity is applied to all samples in an experiment.
To verify that phosphorylation fraction in a sample can be readily determined with the
proposed DRIP-Q strategy, the phosphorylation fraction (x) calculation (Eq 3d) was assessed using
the data already acquired as a test case. To do this, an experimental phosphorylation fraction was
calculated for each sample by applying the observed peak ratio y and the average a value from Table
2 to Eq 3d. This was done for both the 8 and 13 µJ laser energy samples. The experimental
phosphorylation fractions were then compared to their known values, and accuracy determined as %
error (Table 2), obtained on the basis of five experimental replicates per sample. The % errors for
the experimental x values fall in the range of 0.07 % - 6.19 % (overall RMS error of 3.35%), and 0.52
% - 5.33 % (RMS error of 2.43%), for 8 and 13 µJ laser energy, respectively. These error values
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suggest that the ionization efficiency ratio a can indeed be applied to the Eq. 3d for accurate isotopefree MALDI quantification of phosphorylation.

Table 2.2 The effect of different MALDI laser energy on the instrument response factor (α) and accuracy (% errors).

8 µJ
Response factor ratio,

xa

a

0.090

0.226

13 µJ

x

% error

(observed)
0.017

0.088

-2.25

Response factor ratio,

a
0.157

x
(observed)

% error

0.008

0.089

-0.89
-2.73

0.110

0.215

0.015

0.103

-6.19

0.154

0.004

0.107

0.140

0.217

0.013

0.133

-5.32

0.157

0.014

0.139

-0.64

0.200

0.231

0.010

0.200

-0.20

0.148

0.005

0.189

-5.33

0.330

0.231

0.012

0.330

-0.07

0.157

0.010

0.328

-0.52

0.670

0.244

0.016

0.682

1.79

0.164

0.002

0.678

1.24

0.255

0.011

0.815

1.89
RMS (%)
3.35

0.172

0.007

0.812

1.55
RMS (%)
2.43

0.800

Average
R.S.D.

0.231
5.70%

Average
R.S.D.

0.158
4.44%

a Phosphorylation fraction of the Pep. 2 mixture of 0.13- 1.12 pmole

2.2.2.4 Linearity, dynamic range and reproducibility
After establishing consistency of the response factor a, across a wide range of
phosphorylation fractions, in three different peptide models (Table 1), the same model peptides are
further subjected to MALDI-MS analysis to investigate the linearity of the equation. The reciprocals
of observed signal ratios (1/y) and the known phosphorylation fractions (1/x) are plotted in Figure
2.3, and good linearity of Eq. 3d is shown among all peptide models with R2 values above 0.996.
The dynamic range of the method is further determined by evaluating the consistency of the
response factors (a) among pep 2 mixtures of unphosphorylated/ phosphorylated peptides (x = 0.5)
with a serial dilution. A consistent signal ratio (1/y) was observed within a concentration range of 7
to 0.04 pmole, shown in Table 2.3 (data shown in Figure 2.4). This suggests that the proposed
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DRIP-Q method is feasible for phosphorylation quantification with a dynamic range of at least two
orders of magnitude, down to 40 fmol of sample on the plate. At levels below this, the spot-to-spot
variability in a increases to less reliable levels (not shown).

B

A

C

D

Figure 2.3. Linearity of double reciprocal equation. The linearity of the double
reciprocal procedure is assessed by comparing the experimentally determined and calculated
double reciprocal plots using phosphorylated and unphosphorylated analogs of (A) peptide
1 (B) peptide 2 (C) peptide 3A and (D) peptide 3B
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Table 2.3 Effect of sample concentration on unphospho- to phospho signal ratio (Sun/Sp)

Amount a (pmole)

Sun/Sp

7.0
3.5
1.7
0.8
0.4
0.04
Average
RMS error

6.94 0.35 b
7.15 0.33
7.50 0.90
6.93 0.62
7.18 0.66
7.12 0.55
7.14 0.21
0.62

a the mixture of LRWGFTTPDKKHQKEPPF and LRWGFTpTPDKKHQKEPPF (x=0.5; 1:1, w/w) by
using13 μJ laser energy
b standard deviation, n=3

To investigate reproducibility, we conducted three experiments in separate days within a two
week period under the same instrumental conditions. Figure 2.5 shows the plots of the
concentration curves for analysis of the pep. 2 mixtrues with different phosphorylation fractions
across the three experiments. Each of the curves was assigned a random range of phosphorylation
fractions. Comparison of the curves demonstrates demonstrated good linearity, with R2 >0.99, and
good agreement among the three concentration curves, with the mean slope of 0.186 and inter-day
CV of 0.65% (n=3).
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Unphospho-pep2
Phospho-pep2

a) 7.0 pmole

b) 3.5 pmole

Relative Intensity

c) 1.7 pmole

d) 0.8 pmole

e) 0.4 pmole

f) 0.04 pmole

m/z

Figure 2.4 Mass spectra of the experiments for dynamic range test in Table 3. Pep 2/
p-pep 2 mixtures (LRWGFTTPDKKHQKEPPF/RWGFTpTPDKKHQKEPPF) with
phosphorylation fraction (x = 0.5) in an amount range of 7.0 – 0.04 pmole were analyzed by
MALDI-MS.

Figure 2.5 Inter-day reproducibility Double reciprocal plots for peptide 2 obtained from three
individual experiments performed on different days in a 2 week period
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2.2.2.5 Validation of phosphorylation quantification by isotope dilution MALDI-MS
The previous studies on model peptide systems demonstrate the ability to monitor the
amount of phosphorylation in a sample using Eq. 3D. Because consistent a values can be obtained
under a variety of conditions, the DRIP-Q method provides a rapid and low-cost strategy for
phosphorylation quantification directly from the observed signal ratios and the a values without
isotopes or chromatography.
In order to validate the proposed DRIP-Q method, it was compared with isotope dilution
MS, an established method previously shown to be a robust and precise quantitative MS platform
for peptide analysis (2011 Kuklenyik). The isotope dilution strategy utilizes heavy stable isotopelabeled internal standards that are otherwise identical to the analyte; because the analyte and
isotopomeric standard have identical chemical structures, they do not suffer from the typical
MALDI-related difficulties of heterogeneous crystal distribution and differential ionization.
However, its effectiveness as a quantitative method is tempered by the need for cost of producing
isotopically labeled standards.
To compare the two methods, mixtures of a peptide 1, AAAAYRAAR and its
phosphorylated form were mixed with 30% (w/w) and 40% (w/w) phosphorylation concentrations (
x = 0.3 and 0.4) were subjected to both methods. To perform the isotope dilution analysis,
phosphorylated and unphosphorylated versions of peptide 1 were both synthesized with unlabeled
or [13C3]-Alanine at the first position. The labeled and unlabeled peptides were mixed in defined
amounts and subjected to MALDI analysis. The results of DRIP-Q method and isotope dilution
MALDI-MS method are compared in Table 2.4.
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Table 2.4 Comparison of the results obtained by the proposed DRIP-Q method and isotope dilution
method.
fraction (x) a

DRIP-Q method

Isotope dilution method

p value b

0.3

0.291

0.018

0.295

0.005

0.58

0.4

0.394

0.017

0.391

0.005

0.63

a mixtures of AAAAYRAAR/AAAApYRAAR with phosphopeptide fraction (0.3, 0.4) in an amount range of 0.9- 2.0 pmole
b t-test (two tails, n=5)

The phosphorylation fraction of each peptide mixture samples was determined at 0.291 and
0.394 in agreement with the results (0.295 and 0.391, p > 0.60) obtained from isotope dilution
method. Quantification by isotope dilution yields a smaller standard deviation than the DRIP-Q
method (1.7-1.8% RSD vs 4.3-6.3% RSD, p < 0.01), a result that could be expected since the use of
isotopic internal standards eliminates some of the intrinsic uncertainty in MALDI quantification.
Furthermore, other groups have reported average RSDs of 16.6% and 7.9 % for label-free ESI LCMS method and Isobaric Tags for Relative and Absolute Quantification (iTRAQ) method,
respectively (2012 Wang). While ESI is thought to be more quantitatively reproducible than
MALDI, the DRIP-Q method performs comparably to or better than these reported methods,
possibly because the MALDI technique allows for longer acquisition time. In this analysis, spectra
from approximately 18,000 laser shots were acquired over 5 minutes (laser firing at a repetition rate
of 60 Hz), allowing for the averaging of much more data than typically available over the elution
time of a peak in LC-MS; indeed MALDI shows substantial improvement in reproducibility as the
number of laser shots increases (Figure 2.6). A similar phenomenon is observed by Johnson et al.
when evaluating the QconCAT isotope label-based phosphorylation stoichiometry methodology
(2009 Johnson). For peptides analyzed by both MALDI and ESI, they observe RSDs of 1.1% 16.2% for MALDI and 2.0% - 30.5% for ESI, with MALDI ionization giving consistently more
reproducible results. Together, these data suggest the variations between DRIP-Q method and
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isotope dilution MALDI-MS method are comparable with excellent accuracy, in spite of no isotope
labeling or calibration curve needed in the proposed DRIP-Q method. The somewhat better
precision of isotope labeling does not lead to an obvious increase in accuracy, and is offset by the
lower cost of the isotope-free DRIP-Q method.
2.2.2.6 Applications
This study provides a simple and accurate quantitative method to determine phosphorylation
by MS, with potential applications for assessing kinase activity and inhibitor potency. Cyclindependent kinases (Cdks) are proline-directed serine/threonine kinases that regulate eukaryotic cell
cycle. Inhibitors of Cdks are currently under investigation as potential therapeutics for cancer and
viral infection (2014 Holcakova, 2011 Cicenas). Here, the DRIP-Q method is evaluated as a method
for assessing the in vitro inhibition of Cdks.
r-Roscovitine and Olomoucine are well known pharmacological ATP-competitive inhibitors
of Cdks. In a recent paper, r-Roscovitine has also been reported as a potential pharmacological Cdk
inhibitor of HIV-1 replication, showing the higher selectivity in inhibiting HIV-1 infected cells than
Olomoucine (2010 Guendel). Peptide 2 (LRWGFTTPDKKHQKEPPF) derived from HIV reverse
transcriptase was subjected to in vitro phosphorylation by Cyclin A/Cdk2. After incubation of kinase,
peptide and ATP, the reaction mixture was subjected to DRIP-Q analysis to determine the IC50
(50% inhibition of the control) values of r-Roscovitine and Olomoucine. The mathematical a value
for the system was determined using a single point measurement of phosphorylated and
unphosphorylated standards (Figure 2.7A), and found to have a value of a = 0.184  0.017. This a
value was then applied to peptide/phosphopeptide signal intensity ratios according to Eq. 3d
without the construction of additional calibration curves. Inhibition plots were generated, and IC50s
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of r-Roscovitine and Olomoucine were found to be 0.92  0.16 μM and 12.28  0.74 μM,
respectively (Figure 7B).

Figure 2.6 Variability in MALDI-TOF MS signal, as measured by the coefficient of variance of
the signal intensity ratios for either a non-isotopomeric (blue) or isotopomeric (red) peptide pair
decreases as a function of increased laser shots for both isotopomeric and non-isotopomeric
pairs. Spectra were acquired using a Waters MaldiMX MALDI-TOF mass spectrometer in
positive reflectron mode using unphosphorylated 13C3 labeled and unlabeled peptide 1 for the
isotopomeric pair, and unphosphorylated and phosphorylated unlabeled peptide 1 for the nonisotopomeric pair. MALDI samples were prepared using the dried droplet method as previously
described using a 1 pmol 1:1:1 mixture of all three peptides (labeled, unlabeled and
phosphorylated) in a saturated solution (solvent 70:29.9:0.1 acetonitrle:water:TFA v/v/v) of
alpha-cyano, 4-hydroxycinnamic acid matrix. Spectra were acquired in manual mode using an N2
laser firing at 60 Hz.
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This suggests that both r-Roscovitine and Ololomoucine have low micromolar inhibitory
activity against the substrate peptide2 in the presence of Cdk2/CyclinA. The inhibitory activity of rRoscovitine is about 10 times higher than Olomoucine for Cdk phosphorylation of peptide 2. Prior
published studies report similar IC50 range of r-Roscovitine (0.65-1.8 μM) (1997 Meijer, 2005 Bach)
and Olomoucine (7- 8.8 μM) (1994 Vesely, 2005 Raynaud) for Cdk2/CycA activity, consistent with
the results that r-Roscovitine has also 10 times more inhibitory acitivity than Olomoucine. The
consistency indicated that the proposed DRIP-Q method may have feasibility to provide a reference
method for simply, fast and accurately quantify phosphorylation with kinase assays.

A

B

2212

100

Relative Abundance

1.54

0
2150

;

2.93

0.18

IC50 = 12.28

0.74 µM

IC 50 = 0.92

0.16 µM

2291

2350

m/z

Figure 2.7 In vitro inhibition of Cdk2 measured by DRIP-Q method. (A) Mass spectra of
mixture of phospho – and unphosphopeptide 2 (0.14 pmole) in a Cdk kinase buffer. The
response factor ratio α was determined from the observed mass spectrometric signal intensity
ratio, y =2.93, and the known phosphorylation fraction, x = 0.65 for the measurements of in
vitro inhibition of Cdk2 phosphorylation of Peptide 2. (B) Inhibitory activities IC50 of
Roscovitine and Olomoucine against Cdk2/cyclin A. Peptide 2 is used as substrate in in vitro
kinase assays.
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2.2.3 Conclusion
In this chapter 2.2, a novel quantitative strategy combined with isotope-free MALDI-MS to
quantify phosphorylation in in-vitro assays is described. No calibration is required in this method.
Based on the proposed DRIP-Q method, phosphorylation concentration in an assay sample was
simply calculated by using its signal ratios on the mass spectrum with the consistent instrument
response factor. Excellent reproducibility, precision, dynamic range and accuracy have been
determined by using three different peptides, containing different phosphorylation sites (Serine,
Threonine, and Tyrosine respectively). Method validation has been carried out by comparing DRIPQ method to an isotope-dilution method. In addition, the method has been successfully applied to
an in vitro assay to monitor the inhibition activity of Cdk inhibitors by determining IC50 values.
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2.3 Label-free MALDI-MS for double-site phosphorylation quantification
Many phosphorylation sites tend to be clustered in disordered or unfolded regions of
functionally important protein domains (2007 Chang, 2012 Fisher). Holt et al. found, for example,
that multiple Cdk1 phosphorylations at rapidly evolving site clusters appear to regulate the evolution
of kinase-signaling circuits (2009, Holt). A gain or a loss of phosphorylation at individual
phosphorylation sites may dynamically trigger a chain of events associated different protein
functions and biological activities. For example, Aquaporin-2 (AQP-2) shows a significant increase
in phosphorylation at Ser-256 in response to short-term vasopressin treatment but, in contrast to
Ser-256, dephosphorylation of Ser-261 occurs upon treatment with vasopressin (2010 Xie, 2006
Hoffert).
MALDI-MS analysis may suffer from some problems when applied to identification and
quantification of the isomeric AQP-2 phosphopeptides, phosphorylated at Ser-256 (pSer-256) and at
Ser-261 (pSer-261). First, the precursor ions of the isomeric phosphopeptides have identical mass in
the full scan MALDI-MS spectra. In addition, MS2 fragmentation of the precursor ions containing
labile serine-/threonine phosphorylation sites by collision-induced dissociation (CID) generates
primary abundant neutral losses of phosphoric acid (m/z 98), resulting in indistinguishable MS2
spectra of the isomeric phosphopeptides.
To solve the MS2 problem, Electron Capture Dissociation (ECD), developed by McLaffery
et al. (1998 Zubarev), and Electron transfer dissociation (ETD) (2004 Syka), induced by Hunt et al.,
have been recently used in tandem MS to generate c- and z- fragments with cleavage sites at N-Cα
bond of the peptide backbone via gas-phase radical process, and leave the side-chains intact (2014
Collins). For phosphorylation analysis, ETD creates MS2 spectra with no loss of phosphoric acid
that show distinguishable fragmentation patterns corresponding to the isomeric phosphopeptide

57

backbones, not the abundant neutral loss of phosphoric acid. However, a problem may occur in
MALDI coupled to ETD is that singly charged peptide ions, the majority of MALDI generated ions,
are not amenable to ETD fragmentation, which requires charge reduction. Moreover, ETD is more
expensive than the common CID for the reason that peptides must react with a large number of free
electrons for efficient fragmentation, and generally the ECD/ETD technique is coupled to a highresolution analyzer, like FT-ICR or Orbitrap for top-down analysis.
Instead, economical CID-MS3 is proposed in the study as an alternative way to analyze two
singly phosphorylated AQP2 peptides at pSer-256 by PKA and pSer-261 by Cdk kinase. Even
though the MS2 of the phosphoAQP2 peptides contain a dominant peak arising from neutral loss of
phosphoric acid, causing identical MS2 spectra of the pSer-256 and pSer-261 (shown in Figure 2.8),
the following MS3 approach provides a platform where the neutral loss peak in MS2 is further
fragmented resulting in the discrete fragment pat terns of remaining peptide backbone of the
isomeric phosphopeptides. As shown in Figure 2.9, MS3 spectra of pSer-256 and pSer-261 are
disguisable with different intensity ratios of the MS3 fragment m/z 1297.75 to 1495.83. This chapter
is to describe a label-free MALDI-CID-MS3 method for relative phosphorylation quantification to
determine AQP2 phosphopeptides of two discrete phosphorylation sites (Ser-256 and Ser-261) by
measuring the change in the intensity ratios of the MS3 fragments.
2.3.1

Materials and methods

Materials
HPLC grade water, acetonitrile, and formic acid were purchased as HPLC grade from Fisher
Scientific (Pittsburg, PA, USA). Synthetic AQP-2 peptide, RQSVELHSPQSLPR and its two
phosphorylated

forms

at

pSer-256

and
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pSer-261,

RQpSVELHSPQSLPR

and

RQSVELHpSPQSLPR, were purchased from Anaspec (Fremont, CA) for the quantitative method
development.
MALDI-MS preparation
AQP-2

Peptide

standards,

RQSVELHSPQSLPR,

and

its

phosphopeptides,

RQpSVELHSPQSLPR, and RQSVELHpSPQSLPR were selected to establish the label-free
MALDI-MS2 quantitative method. 1 μL of the sample mixtures of the unphospho- and
phosphopeptide standards with various phosphorylation fractions was mixed with 9 μL of matrix
solution of either a saturated aqueous solution of a-Cyano-4-hydroxycinnamic acid (CHCA) (SigmaAldrich, St. Louis, MO, USA) in 0.1 % trifluoroacetic acid/acentonitrol (30/70, v/v) or 2,5Dihydroxybenzoic acid (DHB) (Acros Organics Morris Plains, NJ, USA) mixed with water /
acetonitrile (50/50, v/v) in a 1:4 ratio (v/v). Then, 1 μL of the peptide mixture with the matrix
solution was spotted on a MALDI plate prior to MALDI-MS analysis.
MALDI-MS/MS analysis
MALDI-MS experiments were carried out on a Thermo LTQ XL linear ion trap mass
spectrometer (Thermo Scientific) was equipped with a MALDI ion source. A nitrogen pulsed laser
at 337 nm was used to ionize analytes. The intensities of the laser were set at 8 μJ for CHCA matrix
samples and at 40 μJ for DHB matrix samples with automated spectrum filter (ASF) off, 10
microscan/step. Automatic gain control (AGC) was set at 30000 for full scans and at 10000 for MSn
scans to regulate the ion amount filled in the trap. The acquire time was set to 4 min with 14,400
laser shots. One microscan was acquired per MS/MS spectrum. The protonated AQP-2 ion (parent
ion) at m/z 1714 subjected to MS2 was isolated for CID with 20% normalized collision energy, an
isolation window at 3 m/z,, an activation q at 0.25 and activation time of 30 ms. A subsequent MS3
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event was triggered where one of the MS2 product ions at m/z 1616 was selected for CID with 25%
or 40 % normalized collision energy. The data were processed by XcaliburTM 2.0.7 software.

In vitro kinase assays
To investigate the feasibility of the method, kinase assays were employed was assayed by
incubating 1 μM AQP-2 peptides with and Cdk1/CyclinB and PKA in different concentration ratios
(0.2 to 0.6 μM, and 0.5 to 0.3 μM for Cdk1/PKA) in the presence of 20 mM ATP and 1x NEBuffer
(50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New England BioLabs Inc.) at
30°C for in a time course (10, 30, 90 min). At each time point, 1 μL of each sample was added into 9
μL of the matrix solution for MALDI analysis.
2.3.2

Results and discussion

2.3.2.1 Mass spectra of p- AQP-2 isomers (pSer-256 and pSer-261)
Phosphopeptide isomers of AQP-2 pSer-256 and pSer-261 have identical not only mass-tocharge ratio but also CID-MS2 fragmentation. The CID-MS2 spectra (Figure 2.8) of the
phosphorylated AQP-2 isomers show a dominant peak corresponding to a neutral loss of
phosphoric acid due to the unstable O-P bond of serine/phosphate. This leads to no difference in
MS2 fragment pattern that can be identified and used for quantification. To resolve the problem, we
proposed to utilize MS3 technique to generate backbone MS3 fragments of pSer-256 and pSer-261,
following the strong neutral loss. In Figure 2.9, a different pattern of m/z 1297 to m/z 1460 was
observed in the MS3 spectra of the isomers. pSer-256 contained higher abundance of MS3 fragment
of m/z 1297, corresponding to y*12 – 2NH3; the reason might be that unexpected phosphate
rearrangement on residue 12 of pSer-256 in MS2 results in the labile structure of MS3 precursor ion,
generating more neutral loss of NH3 around residue 12.
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Figure 2.8 MS2 fragmentation of pSer-256 and pSer-261.
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Figure 2.9 MS3 fragmentation of pSer-256 and pSer-261.
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2.3.2.2 Mathematic Approach for double phosphorylation site quantification
The method proposed for double phosphorylation quantification is based on the difference in
intensity ratios of MS3 fragments (m/z1297 (f1) to m/z 1460 (f2)) of AQP-2 phosphopeptides (pSer256 and pSer-261). It requires the assumption that MS3 fragment ratios of individual
phosphopeptide (α for pSer-256 and β for pSer-261) remain constant while the amount of the
phosphopeptide changes.
The MS3 fragment ratios of pSer-256 and pSer-261 can be represented as:
𝑓1p 256
𝑓2p 256

𝑓1𝑝 261
𝑓2𝑝 261

=α

(Eq. 1a)

=β

(Eq. 1b)

where f1p256

and f2p256 represent signal intensity of MS3 fragments m/z1297 and m/z 1460,

respectively for pSer-256; f1p261 and f2p261 for pSer-261.
Another assumption is that signal responses are directly proportional to sample
concentrations. Therefore, taking the amount of phosphopeptides, A p256 and A p261 into account,
f1p256, f2p256, f1p261, and f2p261 in Eqs. 1 can be represented as:
f1p256 = α A p256

(Eq. 2a)

f2p256 = A p256

(Eq. 2b)

f1p261 = β A p261

(Eq. 2c)

f2p261 = A p261

(Eq. 2d)

where if A p256 = A p261, then f2p256 = f2p261 (which we has confirmed experimentally in Table 5)
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Table 2.5 Normalized intensity of MS 3 fragments of f1 and f2 for pSer-256 and pSer-261 AQP2
phosphopeptides
2 μM
10 μM
f1
f2
f1
f2
m/z
1297
1459
1297
1459
pSer-261
48.93
33.89
47.74
32.54
pSer-256
29.4
34.03
29.02
33.53

In analyzing a mixture of pSer-256 and pSer-261, Eqs 2a-d can be combined and the MS3 fragments
𝑓1

ratio ( 𝑓2𝑚𝑖𝑥 ) becomes:
𝑚𝑖𝑥

𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥

=

α 𝐴𝑝 256 + β 𝐴𝑝 261
𝐴𝑝 256 + 𝐴𝑝 261

where the

𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥

(Eq. 3)

is proportional to sample amount fraction, either𝐴

Letting the amount ratio

𝐴256
𝐴261

𝐴𝑝 261
𝑝 256 + 𝐴 𝑝 261

= x, and the MS3 fragments ratio (

𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥

or 𝐴

𝐴𝑝 256
𝑝 256 + 𝐴 𝑝 261

.

) = Rmix, the equation

becomes:
𝑅𝑚𝑖𝑥 =

α𝑥+ β

(Eq. 4)

𝑥+1

According to the proposed Eq. 4, the amount fraction of pSer-256 to pSer-261 can be
calculated by using the constant MS3 fragment ratios α and β, obtained from analyzing pSer-256 and
pSer-261 standards, and observed MS3 fragments ratio Rmix. In other words, this method only
requires determination of α and β, and therefore avoids time-consuming calibration curve
construction.
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2.3.2.3 Assumptions for the proposed Eq. 4
In 2.3.2.1, we describe how the mathematic approach is established for double phosphorylation
site quantification, but the proposed Eq. 4 requires two plausible assumptions: 1) It requires the
assumption that MS3 fragment ratios of individual phosphopeptide (α for pSer-256 and β for pSer261) remain constant while the amount of the phosphopeptide changes; 2) signal responses are
directly proportional to sample concentrations. With the proposed Eq. 4, the amount fraction (x) of
pSer-256 to pSer-261 can be readily determined by applying the MS3 fragment ratio, α or β, for pSer256 or pSer-261 and the MS3 fragment ratio of a mixture shown on a mass spectrum (Rmix). To
verify the mathematic approach with Eq. 4, the assumptions must be demonstrated.
According to the assumption 1, for the Eq. 4 to hold, α and β must be constant. To
investigate this, β of pSer-261 was evaluated by analyzing pSer-261 samples over a range of amount
from 0.20 pmole to 1.00 pmole. According to the data in Table 2.6, the β value of pSer-261 is
found to be consistent across the amount range with standard deviations varying from 0.012 to
0.025. The overall RMS error for across the experimental β values is 0.013 (1.52% of the averaged β
value). The consistency of the β value observed in agreement with our assumption for developing
Eq. 4 that α and β values remain constant even when the amount of the phosphopeptide changes
shows the potential for utilizing Eq. 4 to relative quantification of doublesite phosphorylation by
using MALDI-MS3 without isotopes and calibration curves.
After the consistency of α and β has been demonstrated, the next step is to investigate if signal
responses are directly proportional to sample concentrations (assumption 2). To do this, pSer-256
and pSer-261 are mixed into 11 mixtures with different amount fraction, e.g. 0% to 100% pSer-261,
at two concentration ranges, 0.02-0.2 μM and 0.1- 1 μM, and subjected to MALDI- MS3 analysis. In
the analysis, the changes in Rmix on mass spectra are expected to represent a linear correlation with
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amount fraction change in pSer-261 in response to pSer-256 in a mixture. The observed Rmix and the
known pSer-261 fraction in the mixtures (% pSer-261) are plotted in Figure 2.10, and good linearity
is shown with R2 values above 0.99 across a wide range of concentration between 0.02 μM and 1
μM.
Taken together, the value of β appears to be constant even when the sample amount changes
analyzed, according with assumption 1; the Rmix is response to a changing fraction of pSer-256 and
pSer-261 in mixtures that accords with assumption 2. These data allow the availability to further
evaluate the proposed Eq. 4 to be applied to MALDI-MS3 analysis for relative quantification of
pSer-256 and pSer-261.

Table 2.6 The effect of sample amounts on R261 consistency
Amount a (pmole)

Ratiosb

0.20

0.885 ± 0.012

0.40

0.851 ± 0.005

0.60

0.862 ± 0.002

0.80

0.860 ± 0.007

1.00

0.885 ± 0.025

Average

0.869

RMS error

0.013

a. AQP-2 phosphopeptide Ser 261, RQSVELHpSPQSLPR
b. m/z 1297 to m/z 1460
c. n=3
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Figure 2.10 The linearity between amount fraction (%pSer-261) and Rmix

2.3.2.4 Dynamic Range and Accuracy
From the previous results, the β value stays unchanged when the amount of pSer-261 analyzed
varies from 0.20 to 1.00 pmole. The remaining question to be resolved in the next piece of the
research is the dynamic range of the proposed method by using Eq. 4. To determine the dynamic
range of the method, the consistency of α of pSer-256 is evaluated by analyzing the pSer-256
standards with a series dilution. A consistency of α was observed within a sample amount range of 1
fmole to 10 pmole, even though R.S.D. was greater than 25 % as the sample amount is at 1 fmole
(Table 2.7). This is because when the concentration is close to detection limit, leading to the spotto-spot variability in Rp261 increases to a less reliable level. Overall, the data suggest the method is
feasible for double phosphorylation quantification with a dynamic range of at least 3 orders of
magnitude, down to 1 fmole of sample on the plate.
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Table 2.7 Dynamic range of the constant (α)
Amount of pSer-256 (pmole)

α

R.S.D.*

10

2.13

1%

1

2.14

1%

0.1

2.15

3%

0.01

2.14

6%

0.001

2.16

27%

* n= 5

To evaluate accuracy of the proposed method, two known mixtures of pSer-256 and pSer-261
(45% and 55% pSer-261) were analyzed with the use of α and β, determined by using individual
phosphopeptide standard under the same instrumental conditions. Also, to validate the proposed
single point method, it was compared with a traditional method by generating calibration curve of %
pSer-261 across a sample amount fraction of 0% - 100 % pSer-261. In Table 2.8, experimental %
pSer-261 were determined at 46.14 and 54.00 % by using the calibration curve method and at 46.89
and 54.49 % by using our proposed single-point method with the use Eq. 4. Both results are in
agreement with the true values at 45 and 55 % pSer-261. Together, the current proposed method
and the conventional calibration curve method offer similar accuracy but the single-point method
would be more convenient and less time-consuming than the calibration curve method.
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Table 2.8 Determination of % pSer-261 by using the proposed single-point
method and conventional calibration curve method.
pSer-261 %

Single-point
method

Calibration curve
method

p valueb

45

46.89 ± 1.24 a

46.14 ± 1.22

0.25

55

54.49 ± 2.41

54.00 ± 2.39

0.41

a n=3
b t-test (two-tails, n=3)

2.3.2.5 Effect of collision energy on double phosphorylation quantification
In tandem MS, different collision energies may vary fragmentation patterns that might
further affect the availability of Eq. 4 when α, β, and observed Rmix are used to calculate the
phosphopeptide fraction (x). Selected ions colliding with insufficient collision energy may lead to
low abundance in MS3 fragments and the precursor ions remaining intact, whereas excessively high
collision energy may produce a higher MS/MS efficiency but this may cause inconsistent breakdown of the precursor ion. To investigate the effect of collision energy on the Rmix values in
response to phosphopeptide fraction (x), pSer-256 and pSer-261 were mixed with a range of sample
amount fraction (e.g. 0% - 100 % pSer- 261), and subject to MALDI-MS3 with collision energy of 25
and 40 C.E. (Figure 2.11). Under the two different collision energies, Rmix observed on mass
spectra show linearly proportional to the known sample amount fractions (x). Experimental sample
amount fractions (xexp) were further calculated by using Eq. 4, the observed Rmix values, and the
previously determined α and β. The values of xexp are in agreement with the known fractions (x) with
less than 3% relative standard deviation (Table 2.9). An important thing to note is that the change
in collision energy can differentially affect the values of α and β, but does not affect the linear
correlation between the observed Rmix values and sample fractions – assumption 2 that our single-
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point method rests on. As a result, care should be taken to ensure that the same collision energy is
applied to all samples in an experiment.
25 C.E.
experimental results
calculated results

2.00
1.50
1.00

y = -0.0116x + 2.2071
R² = 0.9964

0.50

MS3 fragment ratio

2.50

2.50

MS3 fragment ratio

40 C.E.
experimental results

2.00

calculated results

1.50
1.00
y = -0.0104x + 1.9834
R² = 0.997

0.50
0.00

0.00
0

50

Rmix
α
β

2.24
1.07

0

100
pSer-261%

20

40

Rmix

RSD
1%
3%

α
β

1.99
0.94

60

80

100

RSD
2%
3%

Figure 2.11 The effect of collision energy on α, β and Rmix.

Table 2.9 Effect of collision energies on the amount fractions, % pSer-261.
Mixtures of pSer-256 and pSer-261 are analyzed under the collision energy at 25
and 40 C.E.
25 C.E
40 C.E.
p261 (%)
calculated p261%
calculated p261%
10
12.5 ± 0.2
7.7 ± 0.1
20
23.7 ± 0.5
22.7 ± 0.4
30
30.7 ± 0.7
30.4 ±0.6
40
43.7 ± 0.6
41.0 ± 0.5
50
50.9 ± 0.3
48.7 ± 1.1
60
65.7 ± 1.9
61.4 ± 2.4
70
72.4 ±1.4
70.2 ± 0.8
80
81.6 ± 2.5
80.4 ± 1.2
90
91.1 ±0.2
88.9 ± 1.5
25
26.4 ± 0.6
26.9 ± 0.3
65
66.7 ± 1.0
65.0 ± 1.1
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pSer-261%

2.3.2.6 Applications to in vitro kinase assays
This proposed method provides a simple and accurate MS3 quantitative method for
phosphorylation quantification of aquporin-2 peptides, which can be phosphorylated at discrete
phosphorylation sites, pSer-256 by c

(PKA) and pSer-261 by Cdk1/Cyclin B. It is important to

distinguish and quantify the pSer-256 and pSer-261 phosphorylation since their phosphorylation
regulation leads to different aquporin-2 protein function. For example, vasopressin mediated PKA
monophosphorylation of AQP2 at Ser-256 has shown to be required to increase water permeability
and water absorption of renal principal cells, but the adjacent phosphorylation of Ser-261,
independent of Ser-256 phosphorylation, does not appear to affect AQP2 trafficking (2010 Moeller).
The proposed single-point method has been demonstrated using Eq. 4 to measure
phosphorylation fraction (x) when AQP-2 pSer-256 and pSer-261 are mixed. To evaluate how Eq. 4
can also facilitate measurements of phosphorylation fraction of pSer-256 to pSer-261 in an in-vitro
kinase assay, the AQP-2 peptides are incubated with ATP in a presence of both PKA and Cdk
enzymes with different ratios (14:5 and 5:7, PKA:Cdk) in a time course (10 -120 min). Figure 2.12
displays change in pSer-261 at a low or high Cdk level in a time course (10 – 90 min). The results
show elevated Ser-261 phosphorylation is observed with a high level of Cdk (5:7 ratio of PKA to
Cdk) in comparison to the results with a low level of Cdk (14:5 ratio of PKA to Cdk). This indicates
that the proposed method is feasible to provide a method for simply and quickly quantifying relative
amounts of phosphorylation at different phosphorylation sites in in vitro kinase assays.
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Figure 2.12 Phosphorylation quantification of AQP-2 treated with PKA and Cdk in a
time course.

2.3.3

Conclusion
An isotope-free, chromatography-free and calibration curve-free tandem MS3 method has

been proposed for relative quantification of AQP-2 double-site phosphorylation. The signal ratios of
phosphopeptide MS3 fragments have been shown to be directly proportional to their relative
amount fractions in a mixture of AQP2 phosphopeptides (pSer-256 and pSer-261). The values of α
and β has further demonstrated to be consistent with the change in sample concentration. A wide
analytical dynamic range (0.01-10 pmole) was shown by analyzing pSer-256 with a constant β value
observed with good precision (<6% R.S.D). The accuracy of proposed the single-point method was
demonstrated in comparison with calibration construction. Furthermore, the method is shown to be
feasible to monitor changes in phosphorylation at differing phosphorylation sites in kinase assays.
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Chapter 3: Investigation of Cdk phosphorylation in HIV-1 reverse transcriptase by mass
spectrometry
3.1 Introduction
3.2 Materials and methods
3.3 Results and discussion
3.3.1 Host Cdks support HIV-1 reverse transcription in CD4+ T cells
3.3.2 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation
3.3.3 Substitution of T216 by Alanine reduces HIV-1 RT
3.3.4 Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation
3.3.5 Cdk2-dependent phosphorylation increases function and stability of HIV-1 RT
3.3.6 p21 (waf-1/cip-1) suppresses Cdk2-dependent HIV-1 RT phosphorylation
3.4 Discussions and conclusion
3.1

Introduction
CD4+T cells are the primary HIV target cells that represent different levels of susceptibility to

HIV-1 among a variety of HIV-1 infected persons. The difference in susceptibility appears to be
related to host specificity of HIV-1 viruses (2004 Ciuffi; 1995 Spira). Thus, a focus of HIV research
has been on identification of relative absence or presence of specific host proteins that modulate the
efficiency of HIV-1 replication by inhibiting specific steps of the viral life cycle. Over the recent
years, there are several host proteins have been identified, but the virus-host protein interaction
network in HIV-1 infected persons still remain unclear (2012 Harris; 2012 Malim).
The host factors may play a dominant role in elite controllers, a small population of HIV-1
infected persons with ability to suppress HIV-1 replication and maintain an undetectable virus level
in the absence of antiretroviral therapy. Interesting, in 2011, a significantly reduced susceptibility of
host CD4+T cells to HIV-1 has demonstrated in two geographically distinct cohorts of the elite
controllers (2011 Chen; 2011 Saez-Cirion). This indicates that specific host proteins may reduce viral
replication steps in the elite controllers and contribute to a CD4+ T cell-intrinsic mechanism of
HIV-1 immune defense. Some classical HIV-1 host factors, such as APOBEC3G, TRIM5α and
BST2, exert direct inhibitory effects on HIV-1 replication in HIV-1 progressors, but reduced
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expression levels of the factors have been observed in CD4+ T cells in elite controllers; these known
factors are unlikely involved in low susceptibility of host CD4+ T cells to HIV-1 infection (2013
Abdel-Mohsen; 2009 Rotger; 2011 Vigneault).
Our collaborators, Lichterfeld et al., have found that a protein called p21 (cip-1/waf-1), a host
protein from the cyclin-dependent kinases inhibitor (CDKI) family, to be uniquely unregulated in
CD4+ T cells from many elite controllers, compared to both HIV-1 negative persons and individuals
with progressive infection (2011 Chen). Besides, knockout studies have shown that p21 inhibits
HIV-1 replication inhibition in CD4+ T cells (2011 Chen), hematopoietic stem cells (2007 Zhang),
and macrophages (2013 Allouch), although the underlying mechanisms for HIV-1 restriction seem
to vary in each of these cell populations. According to Lichterfeld, after knocking out p21 by
siRNA, the susceptibility to HIV-1 significantly increases. More interestingly, the resistance was due
to less effective reverse transcription of HIV-1 and HIV mRNA transcription from proviral DNA
(2011 Chen).
One proposed hypothesis is that instead of blocking HIV-1 replication by directly interacting
with virus proteins, the host p21 protein may indirectly block HIV-1 replication through reducing
the functional activity of HIV-1 dependency factors, cyclin-dependent kinases (Cdks). In this
project, we show that HIV-1 reverse transcriptase (RT) is a substrate for Cdk2-dependent
phosphorylation at a highly conserved Thr 216 residue on the p66 domain (between the finger and
palm subdomains) and on the domains p51, the structure shown in Figure 3.1. The Cdk2
phosphorylation of RT is demonstrated to be functionally relevant for maintaining RT activity,
stability and viral fitness, and can be effectively blocked by p21. Thus these data suggested a novel,
indirect mechanism for inhibition of HIV-1 reverse transcription by the human host protein p21
indirectly blocking Cdk2 phosphorylation of HIV-1 RT in elite controllers.
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Figure 3.1 The crystal structure of HIV-1 RT complexes with ds-DNA. HIV-1 RT is a
heterodimer composed of the following two domains p66 and p51. The active sites are on the p66
domain containing the subdomains called fingers (blue), palm (red), thumb (green), and RNase H
(orange). The p51 domain, a proteolytic cleavage product of p66, has a structural role in stabilizing
the structure of RT. (Singh 2010)

3.2

Materials and methods

In vitro kinase assays. 5μM HIV-1 RT peptides or RT proteins were subjected to a kinase assay in
the presence of 1x NEBuffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New
England BioLabs Inc.) and incubated with 2 mM ATP and 550nM of indicated recombinant Cdk
(Life Technologies) at 30°C for 1 or 3 h, as indicated. The kinase reaction was stopped by addition
of SDS-PAGE loading buffer. Subsequently, proteins or peptides were analyzed by western blot or
mass spectrometry.
Peptide analysis. Mass spectrometric analysis of ex-vivo kinase assay products was performed by a
Thermo LTQ XL linear ion trap mass spectrometer (Thermo Scientific) equipped with a vacuum
MALDI source. Synthetic HIV-1 RT peptide samples were mixed with saturated α-Cyano-4hydroxycinnamic acid, CHCA (Sigma-Aldrich) in 0.1% trifluoroacetic acid: acetonitrile (70:30, v/v).

74

A 1.0 µL aliquot of sample/matrix mixture was dispensed onto the MALDI plate, and the solvent
evaporated at room temperature.
In gel digestion. RT samples separated by NuPAGE and the protein bands were cut out and
digested by lysyl endopeptidase (Lys-C, Promega) at 37 °C for 4 h. The enzyme Lys-C was added to
a final substrate-to-enzyme ratio of 40:1 with 50 mM ammonium bicarbonate, pH 8.5. After
digestion, POROS 20 R2 resin (Applied Biosystems) was added into the digested RT samples for
extraction at 4°C for 4h. Prior to MALDI mass spectrometric analysis, the digests were desalted
using ZipTip (Millipore) and eluted with CHCA MALDI matrix solution from resins directly onto a
MALDI plate, and analyzed in single-stage, MS2 and MS3 modes. Protein bands were identified using
Mascot (Matrix Science, Boston, MA). Identification of phosphopeptide peaks and interpretation of
MS2 and MS3 spectra was performed manually, with the assistance of PAWS sequence analysis
software (Genomic Solutions, Winnipeg, CA) and ProteinInfo (Rockefeller University, NY;
http://prowl.rockefeller.edu) to calculate theoretical molecular weights.
Western blots. Protein lysates were prepared from cells infected with indicated viral constructs for
48 hours, using Radio-Immunoprecipitation assay buffer (Sigma) supplemented with the Halt
protease and phosphatase inhibitor cocktail (Pierce). Following denaturation at 95°C for 10 minutes,
samples were resolved on NuPAGE Bis-Tris 4-12% gels (Invitrogen), electroblotted to PVDF
membranes (Life Technologies) and blocked with bovine serum albumin (Sigma). Blots were
hybridized with monoclonal antibodies against indicated proteins (p21: clone C-19 (Santa Cruz)
1:1000 dilution; Cdk1: clone 5A6 (Thermo Scientific) 1:1000 dilution, Cdk4: clone PA5-14445
(Thermo Scientific) 1:1000, Cdk9: clone: PA5-19674 (Thermo Scientific) 1:250, Cdk2: clone 78B2
(Cell Signaling) 1:1000 dilution, Cdk7: clone MO1 (Cell Signaling) 1:2000 dilution, Lamin B1: ). For
detection of phosphorylated HIV-1 reverse transcriptase, blots were hybridized with antibodies
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against phosphorylated HIV-1 reverse transcriptase (1:800 dilution), generated by vaccination of
rabbits with the phosphorylated target peptide (LRWGFTpTPDKKHQKEPPF) according to
standard procedures by a commercial manufacturer (ThermoFisher Scientific). Selective reactivity
against the phosphorylated target peptide, and not against the corresponding unphosphorylated
peptide, was confirmed by Elisa assays. Detection of non-phosphorylated HIV-1 RT was performed
using a commercially available antibody (1:2000 dilution, AB63911 (Abcam)). Control hybridizations
were performed with a β-actin–specific antibody (1:5000 dilution, clone AB8224, Abcam). After
washing, membranes were probed with Cy5-labeled secondary antibody at 1:2500 dilution (ECL
Plex, GE Healthcare) for 1 h for chemifluorescence detection by Typhoon 9410 (Amersham
Biosciences), using excitation/emission wavelengths of 649/670. Alternatively, signals were
visualized using secondary goat-anti-rabbit antibodies labeled with IRDye 800CW, followed by
quantification of signals using Odyssey Image System (Li-Cor) and Image J software (NIH).
Determination of HIV-1 RT Stability. Recombinant HIV-1 RT was phosphorylated by a Cdk
kinase assay followed by limited proteolysis with subtilisin (Sigma-Aldrich). The 0.16 mg/ml RT
samples were incubated with subtilisin protease (1 mg/ml) in 100 mM Tris (pH 8.5) buffer at 30_C
for 2, 30, 60, 120, 180, or 240 min (Serrano et al., 1984). For analysis, the collected samples were
heate d with SDS sample buffer at 90 °C, alkylated with iodoacetamide, and separated by SDS gel
electrophoresis. Then, the gels were fixed in 40% methanol and 10% glacial acetic acid for 1 hr and
stained with SYPRO Ruby Protein Gel Stain (Life Technologies) under dark conditions overnight.
After being washed twice in 10% methanol and 7% glacial acetic acid for 1 hr, the stained gels were
scanned on a Typhoon 9410 Imager with a green 532 nm excitation laser and 610BP30 emission
filter. Densitometry quantification was performed with ImageQuant software (Molecular Dynamics).
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Functional Assessment of HIV-1 RT. After in vitro kinase assays, 0.25 U of RT and phospho-RT
were analyzed with the EnzCheck RT assay (Life Technologies). The HIV-1 RTs were incubated
with 0.125 mg/ml Oligo d(T)16 primer, 2.5 mg/ml poly(A) ribonucleotide template, and 5 mM
dTTP at room temperature for 10, 20, and 30 minutes. The reaction was quenched by adding
EDTA, and the RT activity was measured with a fluorometric assay.
Statistical Analysis. Data are expressed as mean and SD or SEM or as box and whisker plots
indicating the median, the 25% and 75% percentile and the minimum and maximum of all data.
Differences between different cohorts or different experimental conditions were tested for statistical
significance with paired or unpaired Student’s t tests as appropriate. A p value of 0.05 was
considered significant.
Patients. Peripheral blood mononuclear cells (PBMCs) from HIV-1-infected individuals and HIV1-negative individuals were used for this study according to protocols approved by the Institutional
Review Board of the Massachusetts General Hospital. All study subjects gave written consent to
participate.
HIV-1 Viruses and Constructs. The -encoding R5-tropic and VSV-G-pseudotyped HIV-1
plasmids were kindly provided by Dr. Dan R. Littman (New York University). Viral particles were
produced by transfecting human embryonic kidney 293T (HEK293T) cells (NIH AIDS Reagent
Program) with the respective HIV-1 plasmids, and, if applicable, pCG-VSV-G, using TransIT-293
(Mirus) in OptiMEM. R5-tropic or VSVG- pseudotyped viral variants encoding for a T216A
mutation, were generated by site-directed mutagenesis by a commercial supplier (Genewiz); the
correct sequence of the variant constructs was confirmed by repeated viral sequencing. Supernatants
containing infectious retroviruses were harvested 48 hr after transfection, centrifuged, and filtered.
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Viral titers were determined by measuring p24 levels in the supernatant of infected HEK293T cells,
and confirmed by measuring TCID50 levels in TZM-bl cells (NIH AIDS Reagent Program).
In Vitro Infection Assays. PBMCs were stimulated in RPMI medium containing 10% fetal calf
serum (FCS), recombinant IL-2 (50 U/ml), and an anti-CD3/CD8 bispecific antibody (0.5 mg/ml).
A homogenous population of activated CD4+ T cells was infected on day 5 with the indicated HIV1 viruses for 4h (R5) or 2h (VSV-G) at 37_C. After two washes, cells were resuspended and plated
at 13106 cells per well in a 24-well plate. The CD4+ T cells were subjected to flow cytometric
analysis of GFP+ CD4+ T cells at 96 hr after infection with GFP-encoding R5-tropic HIV-1 or 48
hr after infection with VSV-G-pseudotyped HIV-1 virus. When indicated, proteasome inhibitors
(MG-132, Millipore) were added at a concentration of 1mg/ml. For replication capacity assays,
CD4+ T cells were infected with either WT or T216A-variant R5-tropic HIV-1 viruses. At indicated
time intervals, supernatants were analyzed by p24 ELISA kit (PerkinElmer). Replication capacities
were calculated by fitting a linear model to the log-transformed p24 concentration with maximum
likelihood models.
siRNA-Mediated Gene Knockdown. CD4+ T cells were suspended in 100 ml transfection
solution (Lonza), and target-specific or control siRNA (Dharmacon) was added at a concentration
of 4 nmol/ml. Then, samples were transferred into nucleofection cuvettes and transfected with T023 in a Nucleofector device (Lonza). Afterwards, cells were resuspended in medium supplemented
with 20% FCS; IL-2 (50 U/ml) was added 2 hr after transfection. Cells were infected with indicated
HIV-1 strains at 24 hr after transfection.
Flow Cytometry. The proportion of CD3+ CD4+ GFP-positive cells was analyzed on an LSRII
flow cytometer (BD Biosciences), and data analysis was performed with FlowJo software (TreeStar).
For imaging flow cytometry experiments, PBMCs were stained with antibodies directed against CD3
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and CD4, fixed, and permeabilized. Subsequently, intracellular staining was performed with p21specific antibodies (clone F-5, Santa Cruz Biotechnology). The samples were run on an ImageStream
Cytometer (Amnis), and data visualization and colocalization analysis were performed with IDEAS
Software (Amnis).
Detection of HIV-1 Reverse Transcripts. Cells were harvested 18 hr after infection of activated
cells with VSV-G-pseudotyped HIV-1 and 48 hr after infection of activated cells with R5-tropic
HIV-1. RT products were amplified from cell lysates with primers and probes hRU5- F2, hRU5-R,
hRU5-P (early RT transcripts), FST-F1, SS-R4, P-HUS-SS1 (intermediated RT transcripts) and
GagF1, GagR1, and P-HUS-103 (late RT transcripts) (Mbisa et al., 2009). CCR5 was amplified as a
housekeeping gene and used for the quantification of input cell numbers (2011 Chen). Serial
dilutions of DNA from cell lysates of the HIV-1-infected cell line HEK293T (provided by Dr.
Frederic Bushman, University of Pennsylvania) were used for reference purposes.
Coimmunoprecipitation Assays. Protein lysates from CD4+ T cells were incubated in spin
columns coated with anti-Cdk2 (clone 78B2; Cell Signaling) for 12 hr at 4°C. After washing, protein
complexes were eluted, boiled, and subjected to SDS-PAGE followed by western blotting with
antibodies against HIV-1 RT (AB63911; Abcam), cyclin A (clone BF683; Cell Signaling), and cyclin
T (clone 8744; Cell Signaling).
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3.3

Results and discussion

3.3.1 Host Cdks support HIV-1 reverse transcription in CD4+ T cells
In Lichterfeld’s recent study, p21 has been found to be associated with the reduction in
HIV-1 susceptibility due to less effective reverse transcription, in which Cdks may be important for
activating RT, and this process is inhibited by p21. To investigate how Cdks play a recognized role
in reverse transcription during the HIV-1 life cycle, the influence of pharmacological Cdk inhibition
on reverse transcription in CD4+ T cells was first studied. Primary CD4+ T cells from HIV-1
negative persons were ex-vivo activated with CD3/CD8 bi-specific antibodies and IL-2, followed by
infection with a GFP-encoding R5-tropic HIV-1 or VSV-G-pseudotyped HIV-1 virus construct in
the presence or absence of Roscovitine or Olomoucine, two chemical inhibitors of Cdks. These
experiments in Figure 3.2A-C demonstrated that pharmacological inhibition of Cdks effectively
reduced the proportion of GFP-positive CD4+ T cells, and the per-cell levels of early HIV-1 reverse
transcripts (minus-strand strong-stop DNA), intermediate HIV-1 reverse transcripts (minus strand
DNA) and late, double-stranded HIV-1 reverse transcription products; similar observations were
made when cells were infected with GFP-encoding VSV-G pseudotyped HIV-1 virus that cuases
single-round infections of CD4+ T cells independently of viral coreceptors (Figure 3.2D-F).
Altogether, these data strongly indicate blockade of HIV-1 reverse transcription by pharmacological
Cdk inhibitors in infected cells with either GFP-encoding R5-tropic HIV-1 or VSV-G-pseudotyped
HIV-1 virus construct, therefore, Cdks might be required for HIV-1 reverse transcription and it is of
interest to better understand the role of the host Cdks, the target molecules for Roscovitine and
Olomoucine, in supporting HIV-1 reverse transcription.
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Figure 3.2 Host CDK supports HIV-1 reverse transcription. Activated CD4+ T cells were
infected ex vivo with GFP-encoding, R5-tropic HIV-1, or GFP-encoding VSV-G-pseudotyped
HIV-1 in the presence or absence of the pharmaceutical CDK inhibitors Roscovitine and
Olomoucine. (A/D ) Representative flow cytometry plots showing infected GFP+ CD4+ cells.
(B/E) Proportions of GFP+ CD4+ T cells after exposure to indicated CDK inhibitors. (C/F)
Quantitative analysis of early, intermediate, and late HIV-1 RT transcripts in CD4+ T cells from
the indicated study groups. All statistical comparisons were performed with Student’s t tests.
*p<0.05; **p<0.01; ***p<0.001. Data are expressed as box and whisker plots indicating the
median, 25% and 75% percentile, and minimum and maximum of all data. These results were
generated by Jin Leng at MGH. (2014 Leng)
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3.3.2 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation
HIV-1 gene products can represent direct targets for phosphorylation by host kinases (2011
Francis). We hypothesized that Cdk2 can support HIV-1 reverse transcription through
phosphorylation of HIV-1 RT, a key enzyme of reverse transcription of viral RNA into dsDNA,
which can further be inserted into host DNA genomes and copied by human machine, leading to
massive damage to the host cells. Cdks are requisite proline-directed serine/threonine kinases with
preference for basic amino acids located c-terminal to the phosphate acceptor (1993 Nigg); therefore
the canonical Cdk substrate motif is S/T-P-X-R/K, where X can be any amino acid(s). The HIV-1
RT protein contains seven such Cdk motifs (Figure 3.3).

Figure 3.3 HIV-1 reverse transcriptase sequence. Seven minimal Cdk phosphorylation
consensus motifs (S/T)P are highlighted in red in the HIV-1 reverse transcriptase sequence.

Synthetic peptides were generated with sequences derived from these motifs and their
surrounding amino acids for an initial rapid screen of potential Cdk phosphorylation sites. Each of
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these peptides was assayed as a Cdk substrate by incubating with ATP and Cdk2/cyclin A,
Cdk2/cyclin E, Cdk7/cyclin H or Cdk9/cyclin T1 (Figure 3.4A), followed by mass spectrometric
analysis.

Robust phosphorylation of the synthetic peptide containing the motif at Thr216

(corresponding to HIV-1 RT amino acid residues [210-227]) was observed using both Cdk2/cyclin
A and Cdk2/cyclin E, and trace phosphorylation was observed at two other peptides with
Cdk2/cyclin A (Figure 3.4A). Phosphorylation was not observed with any other HIV-1 RT peptides
harboring Cdk phosphorylation motifs (data not shown). When the [210-227] peptide was incubated
with Cdk2/cyclin A for 0, 1 and 2 hours, a time-dependent increase in mass spectral signal at +80
mass units (corresponding to covalent addition of HPO3) was observed (Figure 3.4B). When
similar assays were performed using Cdk7 or Cdk9, the positive control peptide, but no
phosphorylation of the [210-227] peptide or any other HIV-1 RT peptides, were observed (Figure
3.5). These findings suggest that phosphorylation of HIV-1 RT occurs site-specifically at Thr216 by
only Cdk2 kinases in vitro. Although Cks1 protein was not used in the in vitro assay, it does not
change the importance of Cdk2 phosphorylation site that is necessary to be phosphorylated prior to
Cks induced multiple phosphorylation.

Figure 3.4 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation. (A): Level of
phosphorylation observed by semi-quantitative MALDI mass spectrometry on synthetic peptides
derived from HIV-1 RT after incubation with indicated Cdks and ATP for 3 hours. “+” denotes
phosphopeptide levels < 1-25%; “++” indicates phosphopeptide levels of 25%-50%; “+++”
reflects phosphopeptide levels >50% of total peptide signal intensity. (B): Time course for in vitro
phosphorylation reaction of synthetic peptide [210-227] incubated with ATP and cyclin A/Cdk2,
assayed by MALDI-selected ion monitoring mass spectrometry.
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Figure 3.5 In vitro phosphorylation reaction of synthetic peptide [210-227] by
cyclindependent kinases. The peptide [210-227] was incubated with ATP and cyclin H/Cdk7,
cyclin T1/Cdk9, or cyclin E/Cdk2 for 3 hours, and assayed by MALDI-selected ion monitoring
mass spectrometry. Phosphorylation is not observed for Cdk7 or Cdk9. Dyrktide was used as a
positive control.

Lichterfeld’s group further conducted ex-vivo infection experiments of CD4+ T cells after
siRNA-mediated knockdown of Cdk2 and Cdk7 in the cytoplasm of CD4+ T R5-tropic or VSV-Gpseudotyped infected cells where HIV-1 reverse transcription occurs. A significant reduction of
proportion of HIV-1 positive cells, and of the frequency of per-cell levels of early, intermediate and
late HIV-1 reverse transcripts has only been observed with the down-regulation of Cdk2, but not of
Cdk7 (Figure 3.6). Of note, silencing of Cdk9 slightly reduced cellular susceptibility to productive
HIV-1 infection, consistent with previous findings (1999 Flores), but had no effect on viral reverse
transcription (Figure 3.7). The findings indicate that Cdk2 is critical for supporting HIV-1 reverse
transcription in CD4+ T cells, corresponding to our prior in vitro observation that HIV-RT has a
selective susceptibility to phosphorylation by Cdk2.
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Figure 3.6 Cdk2 supports HIV-1 reverse transcription. (A/D): Representative flow cytometry
plots showing infected GFP+ CD4+ cells. (B/E): Proportions of GFP+ CD4+ T cells after exposure
to indicated Cdk inhibitors or Cdk-directed siRNAs. (C/F): Quantitative analysis of early,
intermediate and late HIV-1 RT transcripts in CD4+ T cells from the indicated study groups. All
statistical comparisons were performed using Student’s t tests. *, p<0.05. **, p<0.01. ***, p<0.001.
These results were generated by Jin Leng at MGH. (2014 Leng)

Figure 3.7 Influence of Cdk1, Cdk4 and Cdk9 on HIV-1 replication. (A-B): Infection of CD4+ T
cells from HIV-1 negative persons with R5-tropic (A) or VSV-G-pseudotyped (B) HIV-1 in the
presence of indicated siRNA. (C-D): Corresponding analysis of HIV-1 reverse transcripts in CD4+
T cells after experimental knock-down of Cdk9. These results were generated by Jin Leng at MGH.
(2014 Leng)
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To further investigate the Cdk2 phosphorylation site at Thr216, the Cdk2- phosphorylated
[210-227] peptide was subjected to tandem mass spectrometry (MS2). Specific fragmentation of the
phosphorylated peptide showed a strong signal at -98 mass units from the parent peptide peak,
corresponding to the neutral loss of phosphoric acid, a diagnostic characteristic of Ser/Thr
phosphorylated peptide ions (Figure 3.8). Furthermore, using backbone fragmentation, we found
that the y11 fragment ion, which runs from Pro217 to Phe227 and does not contain Thr216, is
observed at a mass indicating no phosphate. In contrast, the y12 fragment ion, which runs from
Thr216 to Phe227, is observed at a mass indicating the presence of a phosphate adduct (Figure 3.8).
Because the two fragments both arise from the singly phosphorylated [210-227] peptide, and are
identical in amino acid sequence except for the Thr216 residue that is selectively contained in the y 12
fragment ion, these data indicate that Thr216 is indeed the Cdk2 phosphorylation site (Figure 3.8).
Since the data suggested that Thr216 represents the only site in HIV-1 RT susceptible to
Cdk-dependent phosphorylation, we performed phosphorylation analyses on the intact HIV-1 RT
protein. Recombinant HIV-1 RT protein was phosphorylated in vitro and subjected to analysis using
western blots. For this purpose, we generated rabbit-derived antibodies that specifically recognized
the HIV-1 RT [210-227] peptide sequence phosphorylated at position Thr216. In western blot
experiments, two RT bands (p51 and p66 subunits) were detected with anti-[phospho-210-227]
antibodies after incubation with ATP and Cdk2/Cyclin A for 30 min (Figure 3.9A). An increase in
the intensity of the phospho-RT bands was observed after incubation for 120 min. To conclusively
determine the phosphorylation site in the RT protein, phosphorylated HIV-1 RT was digested by
endoproteinase Lys-C and the digests were analyzed by mass spectrometry. A mass spectral peak at
m/z 2413 was observed in the spectrum arising from the Cdk2-phosphorylated but not the
unphosphorylated HIV-1 RT digest. This peak corresponds to the phosphorylated Lys-C peptide
[202-220], containing the Thr216 Cdk phosphorylation site (Figure 3.9B, bottom panel).
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Phosphorylation at Thr216 was confirmed by MS2 and MS3 fragmentation (Figure 3.10). In
contrast, the spectrum of the unphosphorylated HIV-RT digest contained a significant peak at m/z
2334 corresponding to un-phosphorylated peptide [202-220] (Figure 3.9B, top panel); that peak
appears substantially weaker in the spectrum from the Cdk2-phopsphorylated RT digest. No other
peaks corresponding to phosphorylation at Cdk consensus motifs were observed in either digest
(data not shown). Together, these data strongly indicate Cdk2-dependent phosphorylation
specifically at Thr216 in HIV-1 RT.
We subsequently analyzed the structural position of the targeted Thr216 residue, using prior
crystal structures of HIV-1 RT (1994 Jager; 1992 Kohlstaedt). We observed that Thr216 lies in β
strand 11 for both the p51 and p66 subunits, situated near the interface between the fingers and
palm of the structure (Figure 3.11A). This solvent-exposed position of Thr216 at the molecular
surface is consistent with its role as a target for cytoplasmic host kinases. In addition, we found that
the targeted Cdk phosphorylation motif (Thr216 and adjacent Pro217) was highly conserved across
more than 5000 viral clade A, B or C sequences derived from the Los Alamos HIV-1 sequence
database (www.hiv.lanl.gov), while adjacent amino acid residues were more variable (Figure 3.11B).
Together, these observations support the notion that the Thr216 residue in HIV-1 RT is susceptible
to Cdk phosphorylation, and functionally and/or structurally important for HIV-1 replication.
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Figure 3.8 MS2 spectrum of the phosphorylated synthetic peptide [210-227] analyzed
using MALDI-LTQ-MS. MS2 fragmentation reveals a strong neutral loss of 98 m/z units,
corresponding to phosphoric acid, characteristic of Ser/Thr phosphorylated peptide ions
(McLachlin and Chait, 2001). The signals with m/z of the backbone fragmentation indicated
that the underlined Threonine residue is phosphorylated. b ions indicate N-terminal peptide
fragments and y’’ ions indicate C-terminal peptide fragments, both with cleavage at the peptide
bond (Biemann, 1990). Phosphate observed in the y’’11 but not the y’’12 ion indicates the
phosphate group is on the Threonine in the seventh, not the sixth, position in the sequence,
which corresponds to Thr216 in the RT sequence.
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Figure 3.9 HIV-1 RT is a substrate for CDK2-dependent phosphorylation. (A): Western blot probed by anti-[phospho-210-227]
primary antibody showing time-dependence of phosphorylation on recombinant HIV-1 RT protein incubated with cyclin A/CDK2 and
ATP. (B): MALDI mass spectra of endoproteinase Lys-C proteolzyed unphosphorylated (top panel) and in vitro cyclin A/CDK2
phosphorylated (bottom panel) HIV-1 RT protein. Signal with m/z corresponding to Thr216 phosphorylated proteolytic peptide is observed
in the phosphorylated but not the unphosphorylated digest.

Ion

m/z

MS2
Sequence

Ion

m/z

MS3
Sequence

b10*

1288.74

IEELRQHLLR

b10*

1288.74

IEELRQHLLR

b11*

1474.82

IEELRQHLLRW

b11*

1474.82

IEELRQHLLRW

b13*

1644.92

IEELRQHLLRWGL

b13*

1644.92

IEELRQHLLRWGL

b14*

1745.97

IEELRQHLLRWGLT

b14*

1745.97

IEELRQHLLRWGLT

b15

1847.02

IEELRQHLLRWGLTpT

b15*

1767.02

IEELRQHLLRWGLTT

b16

1944.07

IEELRQHLLRWGLTpTP

b16*

1864.07

IEELRQHLLRWGLTTP

b17

2059.10

IEELRQHLLRWGLTpTPD

b17*

1979.10

IEELRQHLLRWGLTTPD

b18

2187.19

IEELRQHLLRWGLTpTPDK

b18*

2107.19

IEELRQHLLRWGLTTPDK

Figure 3.10 MS2 and MS3 spectra of Thr216 [202-220] phosphorylated Lys-C proteolytic RT
peptide. In MS2 spectrum, a strong neutral loss of phosphoric acid indicated the presence of
phosphate, and the minor peaks representing backbone fragmentation showed the phosphorylation
occurs on the underlined Threonine (in the CDK motif). m/z consistent with phosphorylation on
the b15 ion but not he b14 ion indicates that the phosphate group is on the Threonine at the 15th
position, which corresponds to Thr216 in the RT sequence. MS3 fragmentation of m/z 2316 (loss of
phosphate in MS2) confirmed the sequence of phosphorylated peptide, by presenting backbone
fragmentation consistent with the 202-220 peptide, but without phosphate addition.
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Figure 3.11 Conservation of Thr 216 in RT. (A): Solvent-exposed position of Thr216 in crystal
structures of HIV-1 RT. (B): Entropy of amino acid residues at position 214-219 in indicated
clade A, B and C HIV-1 RT sequences obtained from the Los Alamos HIV-1 sequence database.
The entropy results are generated by Jin Leng at MGH. (2014 Leng)
3.3.3 Substitution of T216 by Alanine reduces HIV-1 RT
To investigate if the Cdk2-dependent phosphorylation of HIV-1 RT has functional
implications for HIV-1 reverse transcription, Lichterfeld’s group used site-directed mutagenesis to
construct a GFP-encoding R5-tropic or VSV-G-pseudotyped HIV-1 variant in which the identified
phosphorylation position Thr 216 is mutated to Ala (T216A), so that the position could no longer
be phosphorylated. The replicative activity of the wild-type and the variant virus was assessed in exvivo activated CD4+ T cells. A direct comparison of the replicative activity of the wild-type and the
variant virus over an 8-day period demonstrated a significantly reduced ability of the variant virus to
produce HIV-1 p24 antigen, which is consistent with viral fitness (Figure 3.12A). Furthermore, the
infection of CD4+ T cells with the T216A variant leads to reduced proportions of GFP-positive
CD4+ T cells in comparison to CD4+ T cells with the wild-type (Figure 3.12B-E). The lower
replicative activity of the variant virus was associated with reduced levels of early, intermediate and
late HIV-1 reverse transcripts, suggesting that the phosphorylation residue Thr216 is needed for
effective

reverse

transcription.

Together,

these

findings

suggest

that

Cdk2-dependent

phosphorylation of HIV-1 RT does contribute to viral fitness through modulation of viral reverse
transcription.
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Figure 3.12 HIV-1 RT T216A mutation decreases HIV-1 reverse transcription (A): HIV-1 p24
antigen production in the supernatant of activated CD4+ T cells infected with similar titers of R5tropic wild-type HIV-1 or the corresponding T216A variant. Data were analyzed by fitting a linear
model to the log-transformed p24 concentration using maximum likelihood models. Right panel
demonstrates one representative experiment, left panel summarizes the relative replication
capacity of wild-type and variant viruses, calculated based on the slope for the p24 production
curves in n=4 experiments. (B/D): Proportions of CD4+ T cells infected with R5-tropic or VSVG-pseudotyped HIV-1 wt and corresponding T216A variants. (C/E): Quantitative analysis of
early, intermediate and late HIV-1 RT transcripts in activated CD4+ cells infected with either wildtype R5-tropic or VSV-G-pseudotyped HIV-1 or the corresponding T216A variants. These results
are generated by Jin Leng at MGH. (2014 Leng)
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3.3.4 Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation
To comprehend the amount of HIV-1 RT phosphorylated in vitro, relative stable isotope
labeling quantification was conducted in conjunction with mass spectrometry. This requires that one
sample be chemically modified with a heavy, stable isotope-containing chemical group, while the
second sample be modified with the same chemical group that contains only regular isotopes. The
two samples are then mixed. Mass spectrometry can distinguish the heavy isotope species from the
first sample, and the corresponding regular isotope species from the second sample. The relative
amounts of that species are then simply obtained from the heavy-to-light peak intensity ratio. In this
experiment, isotope is introduced as deuterated methyl groups after in-gel proteolysis. Free amines
from lysine side chains and peptide N-termini are dimethylated either with regular hydrogencontaining methyl groups (2 x CH3, for the unphosphorylated sample) or with doubly-deuterated
methyl groups (2 x CD2H, for the phosphorylated sample) (Figure 3.13A). The regular isotopelabeled unphosphorylated RT peptides are then mixed with the heavy isotope-labeled
phosphorylated RT peptides, and subjected to MALDI-MS analysis.
Relative quantification of T216 phosphorylation is determined by measuring the decrease in
the abundance of unphosphorylated proteolyic peptide fragment ion spanning residues 202-218.
Peak intensity of the unphosphorylated T216-containing peptide is decreased for deuterated, Cdktreated RT (red bar, m/z = 2091.6) relative to regular, RT with no kinase treatment (blue bar, m/z =
2087.6) (Figure 3.13B). These measurements are obtained from the b17 fragment ion spanning RT
residues 202-218 arising from the MS2 fragmentation of Lys-C proteolytic peptide spanning residues
202-220. The MS2 fragment ions are used to increase specificity and decrease chemical noise.
Quantitative results are derived as the second isotope after deconvolving the overlapping isotope
distributions of the H- and D-containing peptides. Similar results are obtained for other, less intense
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fragment ions of the same parent peptide (not shown). Internal standard spectra (inset) are used to
correct for potential differences in peptide recovery. By using dimethyl-based stable isotope to
determine in vitro phosphorylation stoichiometry for the p51 and p66 subunits of HIV-RT, the
results showed that 92.3% Thr 216 on p51 and 62.1% Thr216 on p66 are phosphorylated in in vitro
kinase assays (Figure 3.13C).

Figure 3.13 Quantification of in vitro phosphorylation of HIV-1 RT by using stable
isotope labeling in conjunction with mass spectrometry. (A) quantification workflow .
(B) MS2 mass spectra of mixtures of Cdk untreated and treated HIV-1 samples, labeled by
regular and deuterated methyl groups. p51 and p66 are two subunits of HIV-1 RT. (C)
Stoichiometric results for phosphorylation on the p51 and p55 subunits of HIV-1 RT.
94

3.3.5 Cdk2-dependent phosphorylation increases function and stability of HIV-1 RT
We subsequently determined whether Cdk phosphorylation of HIV-1 RT directly modulates
the enzymatic activity of reverse transcriptase. For this purpose, HIV-1 RT was exposed to
Cdk2/cyclin A, which resulted in 92% and 62% phosphorylation of the p51 and p66 RT subunits,
respectively; unphosphorylated HIV-1 RT was used as a control. Either HIV-1 RT was incubated
with a poly (A) template, oligo dT primer and dTTP, followed by monitoring of RT activity via the
formation of RNA-DNA heteroduplexes. These experiments demonstrated an increased enzymatic
activity of phosphorylated HIV-1 RT, suggesting that Cdk2 phosphorylation supports the functional
activity of the enzyme (Figure 3.14A).
Since phosphorylation often influences the stability of proteins (2011 Nishi), we considered
whether Cdk2 might serve to modulate the resistance of HIV-1 RT to proteolytic degradation.
Limited proteolysis was employed as an in vitro tool for probing HIV-1 RT stability. Cdk2/cyclin Aphosphorylated and un-phosphorylated HIV-1 RT was incubated with subtilisin protease - known to
be sensitive to the three-dimensional conformation of its substrate - at different reaction times
ranging from 2 min to 4 hr. (Figure 3.14 B/C). These experiments demonstrated a markedly more
rapid decrease in band intensity for the unphosphorylated HIV-1 RT. Indeed, after 180 minutes of
exposure to subtilisin, gel densitometry indicated that 45% of the phosphorylated RT, versus only
20% of the unphosphorylated RT, remained undigested, demonstrating that Cdk2 phosphorylation
protects HIV-1 RT from protease cleavage. However, CD4+ T cell infection with the viral wt or the
T216A variant in the presence of proteasome inhibitors resulted in proportionally equal increases in
HIV-1 replicative activity, suggesting that proteasomal degradation of HIV-1 RT is unaffected by
Cdk2-dependent RT phosphorylation (1998 Schwartz). Together, these data indicate that Cdk2
phosphorylation of Thr216 protects HIV-1 RT from protease activity, and suggests that its
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mechanism of action may be to stabilize HIV-1 RT against intracellular proteases, perhaps via
conformational modulation.

Figure 3.14 Cdk2-dependent phosphorylation enhances activity and stability of HIV-1 RT.
(A) Assessment of the functional activity of phosphorylated and unphosphorylated HIV-1 RT in a
cell-free system. One representative experiment out of 4 is shown. (B) SDS-PAGE gel of limited
proteolysis of unphosphorylated (left) and cyclin A/Cdk2 phosphorylated (right) HIV-1 RT time
course. Degradation of the p66 and p51 subunits of HIV-1 RT (major upper and lower bands,
respectively) is shown as a function of time and phosphorylation state. (C) Quantitative
comparison of the rates of proteolysis for unphosphorylated and phosphorylated HIV-1 RT as
measured by SDS-PAGE gel densitometry of Sypro Ruby-stained HIV-1 RT.

3.3.6 p21 (waf-1/cip-1) suppresses Cdk2-dependent HIV-1 RT phosphorylation.
The cell-intrinsic Cdk inhibitor p21 (waf-1/cip1) is upregulated in CD4+ T cells from many
persons with natural control of HIV-1 replication (“elite controllers”) (2011 Chen), raising the
possibility that p21 has a functional role for inhibiting Cdk2-dependent phosphorylation of reverse
transcriptase and reducing the efficacy of viral reverse transcription in CD4+ T cells from these
patients. To investigate this, we first analyzed the subcellular localization of p21 in CD4+ T cells
from elite controllers, using high-throughput imaging flow cytometry, an approach that combines
standard flow cytometry with high-resolution fluorescence microscopy. For this purpose, CD4+ T
cells from elite controllers and HIV-1 negative persons were intracellularly stained with antibodies
directed against p21, and with the nuclear dye DAPI. This analysis demonstrated that p21 was

96

located both in the nuclear and in the cytoplasmic subcellular compartment (Figure 3.15A/B), and
did not change substantially after in vitro activation. Importantly, we observed that total, nuclear and
cytoplasmic cell-associated p21 was expressed at significantly higher levels in CD4+ T cells from elite
controllers compared to HIV-1 negative persons, but differences were more obvious for
cytoplasmic p21 than for nuclear p21 (Figure 3.15A-B). This suggests that p21 may be functionally
relevant for inhibiting Cdk2-dependent phosphorylation of HIV-1 reverse transcriptase in the
cytoplasm of CD4+ T cells from elite controllers. To further investigate this, we analyzed HIV-1
reverse transcription in CD4+ T cells from elite controllers after electroporation with p21-specific
siRNA, which resulted in effective reduction of p21 protein expression. We found that following
infection of CD4+ T cells from elite controllers with either R5-tropic or VSV-G-pseudotyped HIV1, siRNA-mediated reduction of p21 expression resulted in enhanced levels of HIV-1 positive cells,
and in increased levels of viral reverse transcripts. Interestingly, such effects were not visible in
CD4+ T cells from HIV-1 negative persons, likely due to lower baseline expression of p21 that
minimizes biological effects of p21 silencing (Figure 3.15C-F). Moreover, p21 knockdown did not
affect HIV-1 replication in CD4+ T cells from elite controllers infected with the T216A variant,
supporting the notion that p21 inhibition of HIV-1 reverse transcription depends on
phosphorylation of Thr216 (Figure 3.15C-F). In addition, we observed that in CD4+ T cells from
elite controllers, the wild-type virus and the T216A variant showed a similar replicative activity
(Figure 3.15G/H), which represented a sharp contrast to the replicative advantage of the wild-type
virus in CD4+ T cells from HIV-1 negative individuals (Figure 3.12B-E); this indicates that the
increased viral fitness associated with RT phosphorylation at position Thr216 is not visible in cells
with high-level p21 expression. Finally, we noted that p21 knockdown led to increased levels of
phosphorylated HIV-1 RT in CD4+ T cells from EC infected with R5-tropic or VSV-G
pseudotyped HIV-1, providing formal evidence for an inhibitory effect of p21 on Cdk2-dependent
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RT phosphorylation (Figure 3.15I). p21 silencing also appeared to increase levels of
unphosphorylated RT, specifically in cells infected with R5-tropic HIV-1 in which p21-mediated
inhibitory effects on viral replication are amplified during multiple rounds of infection. Taken
together, these data suggest that high-level p21 expression can indirectly inhibit viral reverse
transcription through blockade of Cdk2-dependent phosphorylation of viral RT.

Figure 3.15 Inhibition of p21 (waf-1/cip-1) Increases HIV-1 Reverse Transcription in CD4+ T Cells
from Elite Controllers. (A): Analysis of the subcellular localization of p21 in CD4+ T cells. PBMCs from
Elite controllers or HIV-1 negative patients were stained with antibodies against CD4 (yellow pseudocolor),
p21 (green pseudocolor) and DAPI (red pseudocolor) and subjected to ImageStream analysis. Selected
images of single-cell analysis plots from an HIV-1 elite controller and an HIV-1 negative patient are shown.
(B): Cumulative average p21 signal intensity in CD4+ T cells from Elite controllers (n=6) and HIV-1
negative persons (n=6) in total, cytoplasmic and nuclear compartments of CD4+ T cells. (C/D): Proportion
of HIV-1 positive CD4+ T cells from EC and HIV-1 negative persons after ex-vivo infection with R5-tropic
or VSV-G-pseudotyped HIV-1 in the presence of siRNA-mediated knock-down of p21. TheT216A variant
virus was used where indicated. (E/F): Corresponding analysis of early, intermediate and late RT transcripts
in elite controllers. (G-H): Comparison of HIV-1 replication patterns of wild-type HIV-1 and the T216A
variant in CD4+ T cells from EC. (G) demonstrates proportion of infected CD4+ T cells, (H) reflects levels
of early, intermediate and late reverse transcripts. (I): HIV-1 RT phosphorylation in CD4+ T cells after
experimental p21 knock-down. CD4+ T cells were transfected with siRNA directed against p21 or control
siRNA, infected with R5-tropic or VSV-G pseudotyped HIV-1 and hybridized with antibody against HIV-1
RT, anti-[phospho-210-227] RT or b-actin. These results are generated by Jin Leng at MGH. (2014 Leng)
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3.4 Discussions and Conclusion
Human Cdks have shown its ability to phosphorylate a wide range of host substrates in vitro
or in vivo, and the phosphorylation events significantly contribute to numerous biological functions,
including regulation of cell proliferation, survival, differentiation, motility, and gene expression. In
addition to cellular regulation, Cdks also play a recognized role in virus-infected cells for regulation,
replication, and maintenance of viral functions, such as transcriptional elongation, RNA initiation
and processing (2008 Durand, 2010 Zydek). In HIV-1 infection, the host Cdks have been mostly
suggested to regulate the post-integration stage of HIV-1.

For example, HIV-1 transcription

elongation depends on the interaction of HIV-1 Tat with host Cdks. HIV-1 RNA polymerase II is
phosphorylated by Cdk9 whose activity is in turn stimulated by Tat phosphorylation catalyzed by
Cdk2 (1999 Flores, 2006 Ammosova) However, a possible impact of Cdks on viral pre-integration
steps has remained unknown. In this study, we examined whether Cdk2 specifically phosphorylates
HIV-1 RT, and whether Cdk2 phosphorylation of RT has regulatory effect on HIV-1 reverse
transcription during HIV-1 pre-integration. Our data indicate Cdk2 phosphorylation of RT on Thr
216 facilitates HIV-1 reverse transcription, supporting the emerging recognition of host kinases as
modulators of HIV-1 replication in human CD4+ T cells where HIV-1 virus exploits the virus-host
interaction on their own purpose for viral propagation as well as survival in human cells.
Considering that Cdk2 has only in vitro phosphorylated the Cdk motif containing Thr 216
among the 7 Cdk consensus motifs of HIV-1 RT in the absence of Cks, therefore we suspect that
Cdk2 might phosphorylate other motifs later after its activity is stimulated by Cks binding with the
phosphorylated Thr216. Although the role of Cks in the control of cell cycle is still elusive, it has
been previously demonstrated that the Cks associate with Cdk-cyclin complexes, modulate their
phosphorylation ability, and target the Cdks to phosphorylated substrates in multisite
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phosphorylation (1996 Pines, 1999 Patra); for instance, Sic1 multisite phosphorylation is stimulated
in the presence of Cks, but the stimulatory effect requires that T5 and T33 of Sic1 are
phosphorylated as Cks binding sites (2011 Koivomagi, 2013 Koivomagi). In another study, Cks
showed no promotional effect on Wee1 hyperphosphorylation by Cdk1, yet Cks binds to the
phosphorylated Cks consensus sites and induce inhibitory phosphorylation in Cdk1 by
phosphorylated Wee1, when the Cks consensus sites on Wee1 are phosphorylated in late
phosphorylation (2013 McGrath). It remains an open question whether the Cdk motif containing
T216 also acts as a Cks-binding consensus site, and it will be interesting to explore conservation of
the other Cdk phosphorylation motifs of RT and the role of multisite phosphorylation in HIV-1
infection in which Cks contributes to the phosphorylation process.
How might HIV-1 RT benefit from Cdk phosphorylation? The addition of phosphate might
cause conformational and functional changes in RT. The HIV-1 RT is a heterodimer comprised of
two separate subunits, referred to as p66 (~ 66kDa) and p51 (~ 51 kDa); the p51 subunit is
processed by proteolytic cleavage of the p66 subunit by the viral-encoded protease. Although p66
and p51 have identical amino acid sequences (first 440 amino acid), they are functionally and
structurally distinct. The p66 subunit contains active sites as an executer of RT functions with the
p51 subunit stabilizing the complex and facilitating RNA/DNA bybrid positioning (2013 Chung),
whereas the functional role of p51 subunit remains elusive. According to the quantitative data,
62.1% and 92.3% Thr 261 on p66 and p51 of RT is phosphorylated in vitro, respectively, suggesting
the Cdk2 phosphorylation may contribute to modulation of the enzymatic activity and stability of
RT and thus results in the enhanced HIV-1 fitness. In agreement with this, the later results showed
Cdk2 phosphorylation indeed increases function and stability of HIV-1 RT.
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An unresolved issue here is that how the Cdk2 dependent phosphorylation can affect HIV-1
reverse transcription during the viral pre-integration stage on the molecular basis of functional and
conformational changes of the complex. With regard to phosphorylation on the catalytic subunit, it
seems to interesting that the highly conserved phosphorylation site, Thr 216 residue, is in immediate
proximity to the hot spots of RT amino acid residues at Thr 215 and Lys 219 of p66 subunit with
known roles for influencing incorporation of nucleotides into viral DNA (2002 Chamberlain, 2010
Tu). Their mutations (T215Y or F, and K219Q) render RT resistant to nucleoside analogue
inhibitor, 3’-azido-3’-deoxythymidine (AZT) (Jacobo-Molina, 1991 Biochemistry), suggesting that
the two residues are associated with the formation of the triphosphate binding site in HIV-1
transcription in the p66 subunit. In line with this, the triphosphate binding may potentially assist
Cdk2 transfers the terminal phosphate from ATP to Thr 216 phosphorylation site during
phosphorylation. Moreover, the p51 subunit of RT has been observed being enzymatically inactive
because of the alternative configuration and the absence of a C-terminal ribonuclease H (RNase H)
domain, but it has a structurally stabilizing contribution to facilitating p66 loading onto nucleic (1998
Harris) and hybrid RNA/DNA binding and orienting the RNA strand for hydrolysis in the p66
RNase H active site (2013 Chung). Prior studies demonstrated that host ERK/MAPK family kinases
could enhance chromosomal HIV-1 integration through the induction of phosphorylation-induced
conformational changes in HIV-1 integrase (2013 Manganaro). Similarly, phosphorylation of the p51
subunit may play a role in establishing or stabilizing particular conformations of RT by forming
more hydrogen bonds, providing structural support.
Because increasing evidence showed that the host Cdk inhibitor p21, a protein best known
as cancer suppressor, seems to retain its ability to suppress HIV-1 replication, p21 has received
much attention in the context of HIV-1 infection. Intensive studies over the past few years
highlighted the p21 is capable of modulating the efficacy of HIV-1 replication in human
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macrophages (2009 Bergamaschi), hematopoietic stem cells (2007 Zhang), and CD4+ T cells (2011
Chen), although it seems likely to have different underlying mechanisms associated with HIV-1
restriction in each cell population. In macrophages, p21 was found to inhibit HIV-1 replication by
blocking dNTP biosynthesis via down-regulating the expression of RNR2 (ribonucleotide reductase
subunit R2), an essential enzyme for the reduction of ribonucleotides to dNTP (2009 Bergamaschi).
In hematopoietic stem cells, inhibition of HIV-1 integration by p21 was observed, while HIV-1
reverse transcripts stay unaffected (2007 Zhang). Interestingly, previous findings suggest that
selective upregulation of the p21 proteins occurs in activated primary CD4+ T cells of HIV-1 elite
controllers, inhibiting transcriptional elongation of HIV-1 mRNA and HIV-1 reverse transcription.
The evidence showed that HIV-1 mRNA transcription affected by p21 was, at least in part, through
the indirect blockade of enzymatic activity of a host enzyme Cdk9, known to phosphorylate RNA
polymerase II for enhancing HIV-1 mRNA elongation. However, it was not clear how p21 affects
HIV-1 reverse transcription during pre-integration stage. Our in vitro and in vivo data in this study
conclusively demonstrate a role of p21 for a cell-intrinsic mechanism underlying the inhibition of
HIV-1 reverse transcription in CD4+ T cells from elite controllers by blocking phosphorylation of a
host enzyme Cdk2, shown its ability to phosphorylate HIV-1 reverse transcription on a highly
conserved residue Thr 216. Taken together, the cell-intrinsic inhibitor p21 shows two distinct
pathways of indirect suppression of HIV-1 infection at HIV-1 replication steps – mRNA elongation
and reverse transcription by indirectly interacting human host cells. Although the indirect inhibition
of p21 appears to be less effective than the inhibition of traditional pharmacological RT inhibitors
by interacting directly with HIV-1 gene products, but the indirect mechanism can more possibly
prevent viral mutational escape, a major cause of drug resistance. This might explain why no
selection of viral escape variants of HIV-1 infected lymphocytic and monocytic cells in the presence
of pharmaceutical Cdk inhibitors was observed in ex vivo cultures (2001 Wang).
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As for the mechanism of host cell control against HIV-1, these data provide very useful
insight into an cell-intrinsic immune defense mechanism in CD4+ T cells from elite controllers,
where Cdk2 phosphorylation of HIV-1 RT, an essential modification for enhancing efficiency of
HIV-1 reverse transcriptase, is inhibited by highly unregulated p21 proteins. Interestingly, a recent
report showed that p21 also regulates the HIV-1 restriction factor by inhibiting Cdk1-mediated
phosphorylation of SAMHD1 into an active form with its ability to restrict HIV-1 during reverse
transcription in macrophages (2014 Pauls). The findings suggest that p21 appears to act as a master
of regulator controlling HIV-1 infection in different HIV-1 replication steps by indirect interaction
with viral proteins. Of many immune responses to HIV-1 infection, the majority of data suggested
the emergence of HIV-specific CD4+ and CD8+ T-cells are correlated to a decline in HIV viral loads
as a result of immune protection (2010 Streeck, 1999 Jin, 1999 Schmitz, 1994 Koup, 1994 Borrow).
However, further data revealed that effective T cell responses are not always necessary for long-term
virus control of HIV-1 infection (2011 Chen, 2011 Jager, 2008 Emu, 1998 Martin). Many HIV-1
elite controllers are, for example, capable of maintaining normal CD4+ T-cell counts and
undetectable levels of HIV-1 replication over very long follow-up periods in the absence of strong
HIV-1-specific CD8+ T cells (2008 Emu). Overall, although different mechanism may act together
or specifically in HIV-1 infected individuals in the synergistic networks among host proteins, viral
proteins and the CD8+ T cell-mediated adaptive immunity, it can be speculated at the moment that
the cell-intrinsic inhibition of Cdk phosphorylation by p21 may provide a clue to induce a long-term,
drug-free remission or a functional cure of HIV-1 infection (2014 Leng).
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Chapter 4: Summary and Future Directions
This thesis contributes to developing MALDI mass spectrometric methods without
expensive isotope labels and time-consuming calibration curves for single- and double-site
phosphopeptide quantification in in vitro assays (chapter 2). Through mass spectrometric techniques,
Cdk2 phosphorylation of HIV-1 reverse transcriptase at a specific site (Thr 216) has been
successfully identified that reveals a cell-intrinsic mechanism of inhibition of HIV-1 reverse
transcription with demonstration of in vivo experiments (chapter 3).
Chapter 2.2 described the results of the DRIP-Q method development and indicated that it
may be worthwhile to utilize label-free and calibration-curve-free MALDI-MS as an easy-to-use and
robust alternative approach to quantifying phosphopeptides for three different peptide models
encompassing phosphoserine, phosphothreonine and phosphotyrosine, and further may be applied
in in vitro assays, such as for testing drug efficacy. The method is not limited by the difference in
MALDI laser energy provided by different MALDI instrument, because the results showed that the
change in laser energies of MALDI does not affect the feasibility of the method if the same energy is
controlled in one set of experiments. The results obtained demonstrated that the DRIP-Q method
provides a wide dynamic range of at least two orders of magnitude and a good reproducibility of
inter-day CV of 0.65 % (n=3). The method was further validated by comparing with an isotope
dilution method that most quantification of phosphorylation relies on, showing the two methods are
comparable with excellent accuracy, and by assessing the in vitro inhibition of Cdks, showing IC50
values of pharmaceutical Cdk inhibitors consistent with the literature.
Although the DRIP-Q method demonstrated its feasibility in in vitro assay, the analytical
performance of the DRIP-Q method will need to be challenged by performing phosphorylation
analysis in more complex sample systems, such as peptide digests from purified phosphoporteins.
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For example, it would be interesting to synthesize the unphosphoryltaed and phosphorylated trypic
HIV-1 RT peptides containing the identified phosphorylation site Thr216 for probing
phosphorylation quantification of HIV-1 RT protein phosphorylation by using the DRIP-Q
method.
In addition, the method can be further refined and expanded into analysis of a larger number
of peptides (In this study, there are only three peptides, one each with pSer, pThr, and pTyr). For
example, a systematic peptide sequences with different number of basic or acidic residues can be
subjected to the proposed DRIP-Q method for testing its general feasibility. The
peptide/phosphopeptide samples can also be assigned to different laboratories, and the results from
the inter-labs can compared to evaluate the performance of the DRIP-Q method.
Chapter 2.3 proposed another label-free, calibration curve-free method by using tandem
mass spectrometric technique for quantification of the double-site phosphorylation of AQP2. This
new method overcomes the difficulty in traditional MALDI-MS analysis of two distinct singly
phosphorylated peptides with an identical mass. With the use of economical CID-MS3, the method
provides an efficient way to quantify singly AQP2 phosphopeptides at each of two discrete
phosphorylation sites (Ser-256 and Ser-261) by measuring the change in the intensity ratios of the
MS3 fragments in response to the amounts of pSer-256 and pSer-261 in a sample mixture. The
results successfully demonstrated two assumptions that support the mathematic approach used in
the method: (1) the relative MS3 fragment intensities of individual phosphopeptide (α for pSer-256
and β for pSer-261) remain constant while the amount of the phosphopeptide changes; and (2) MS3
signal responses are directly proportional to sample concentrations. It has been observed that the
change in collision energy may affect the values of α and β, but does not affect the feasibility of the
method by providing the same collision energy to all samples in an experiment. The data suggest
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that the method provides a wide dynamic range of at least 3 orders of magnitude and good accuracy
with comparable results to the traditional calibration curve method. The method was further
effectively applied to an in vitro kinase assay to measure the change of the phosphorylation at Ser-256
and Ser-261 of AQP2 in the presence of both PKA and Cdk1/Cyclin B.
One of the important future extensions of the work involves application of in vitro kinase
assays by assessing AQP2 double-site phosphorylation in the presence of two different kinases. In
this study, we observed an increase of pSer-261 at a high level of Cdks. However, insufficient
consideration given to this method is that the production of doubly phosphoAQP2 peptides can
lead to an unpredictable decrease in the absolute amount of singly phospho- and
unphosphopeptides. In order to accurately quantify the total absolute amount of single
phosphorylation of AQP2 by PKA or Cdk1 in an in vitro kinase assay, there is a need to obtain
standards of doubly phosphoAQP2 peptides on Ser-251 and Ser-261. A peak of doubly
phosphoAQP2 will be observed on a MS full scan spectrum with a mass shift of two-phosphateaddition from the unphosphoAQP2 peptide. The amount of occurring double phosphorylation can
then readily measured by monitoring the change in signal intensity of the peak of doubly
phosphoAQP2 in a sample, compared to the standard. Therefore, the proposed method is able to
quantify singly phosphopeptides on the sites Ser-256 or Ser-261 with consideration of the double
phosphorylation event. A further extension of this methodology will be to apply it to
phosphoprotein digests, to quantify double-site phosphorylation in the context of a whole protein.
Chapter 3 revealed a cell-intrinsic mechanism of blocking HIV-1 reverse transcription by
discovery of Cdk2 phosphorylation site at a highly conserved Thr 216 of HIV-1 RT. After assessing
phosphorylation of the HIV-1 RT protein using a variety of Cdk kinases in an in vitro kinase assay,
the results show that Cdk2 imparts Cdk- and site consensus- specificity to RT phosphorylation. The
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host Cdk2 kinase does not only phosphorylate HVI-1 RT protein but also supports HIV-1 reverse
transcription. Site-directed mutagenesis experiments was conducted based on substitution of Thr
216 by Ala, demonstrating the vital contribution of the Cdk2-dependent phosphorylation of RT to
viral fitness through modulation of viral reverse transcription. In the in vitro phosphorylation assay,
the results of dimethyl-based stable isotope quantification showed that 92% Thr261 on p51 subunit
of RT and 62.1% Thr216 on p66 subunit of RT are phosphorylated. The in vitro phosphorylated RT
was then subjected to an enzymatic activity assay and limited proteolytic experiments, suggesting
Cdk2 phosphorylation does increase the functional activity and stability of HIV-1 RT. Further p21
knockdown experiments provide strong evidence that the intrinsic Cdk inhibitor, p21, can indirectly
inhibit HIV-1 reverse transcription and reduce the efficacy of viral transcription in CD4+ T cells
from elite controllers by blocking Cdk2 phosphorylation of RT.
However, there are several particular questions to the proposed cell-intrinsic mechanism: (1)
What does Cdk2 phosphorylation affect a conformational change of the RT protein? (2) Whether
Cks1 can be involved the proposed mechanism by which the Cks1 protein may modulate
processivity of Cdk2/CyclinA? And (3) How do Cdk kinases associate with other viral HIV-1 Cdk
phosphorylation substrates, leading to a change in HIV-1 viral replication?
As mentioned above in Chapter 3, the RT protein was shown to be phosphorylated at the
two subunits, p66 and p51, known as to have a functional role and structural role, respectively. The
Cdk2 phosphorylation site is situated near the interface between fingers and palm subdomain of the
RT structure. It has been reported that, for the p66 subunit, the palm subdomain accommodates the
enzymatic active site; the finger subdomain stabilizes the RNA template; the thumb subdomain
interacts with the DNA strand (2014 Nowak), and the p51 subunit stabilized RT heterodimer
structure that is required for its function (2005 Depollier). In this study, the addition of a phosphate
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group during Cdk2 phosphorylation may result in a significant conformational change associated
interaction with RNA template as well as the DNA strand, and dimerization of the two subunits,
and consequently cause the change in enzymatic activity of RT.
In addition, it is interesting to consider that experiments assessing Cdk2 phosphorylation in
the presence of Cks1 to investigate the intriguing role of Cks1 in the RT phosphorylation. The
phosphorylated Thr216 site might also be a Cks1 consensus site containing the Cdk-acceptor site
(TP) and a bulky hydrophobic residue Tryptophan in the -3 position that facilitates binding of Cks1
to phospho216-Cks1. In this study, the in vitro kinase assay performed in the absence of the Cks1
protein might have underestimated the other potential phosphorylation sites that may be induced by
Cks1. Considering the western-blotting data cannot give a clue because the data were obtained by
probing Cdk2 phosphorylation with only Thr216 specific antibodies; therefore the Cks1 study will
be one of the important future directions for better understanding of the cell-intrinsic mechanism.
One more future work will be aimed at characterization of any potential phosphorylation
sites on other viral proteins. The pharmaceutical Cdk inhibitors were consistently observed to inhibit
HIV-1 replication with no selection of viral escape variants in the infected lymphocytic and
monocytic cells (2001 Wang). In addition, another cell-intrinsic mechanism of HIV-1 restriction
associated with the Cdk inhibitor p21 was recently discovered that p21 acts as a negative regulatory
master to reduce HIV-1 reverse transcription through blocking Cdk1-mediated phosphorylation of a
restriction factor SAMHD1. Altogether, Cdk phosphorylation appears to be essential for HIV-1
virus to harnesses host machinery to replicate. In order to comprehend the whole complex Cdk
phosphorylation network in HIV-1 replication, it would be necessary to identify other potential
phosphorylation sites on the entire HIV viral proteins by using similar strategies to this research in
the future studies. The deeper exploration of the role of phosphorylation in HIV-1 replication may
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offer long term potential for development of prophylactic or therapeutic strategies for HIV-1
patients.
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